GMO ETF Trust 提交截至2026年8月31日的半年度股东报告
GMO ETF Trust (0001981627) (Filer)
GMO ETF Trust 提交了截至2026年8月31日的半年度股东报告,覆盖2026年3月1日至8月31日,披露旗下多只ETF的未经审计财务报表、投资组合、费用及业绩数据。报告列出各基金净资产、持仓与行业配置,以及六个月NAV回报;例如 Domestic Resilience ETF 为2.30%,International Value ETF 为8.96%。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-23895
GMO ETF TRUST
(exact name of registrant as specified in charter)
GMO ETF Trust
53 State Street, Boston, Massachusetts 02109
(Address of principal executive offices) (Zip code)
The Corporation Trust Company
1209 Orange Street
Wilmington, Delaware 19801
(Name and address of agent for service)
Registrant’s telephone number, including area code: (617) 330-7500
Date of fiscal year end: February 28
Date of reporting period: August 31, 2026
Item 1. Report to Stockholders.
| (a) | The following is a copy of the report transmitted to stockholders pursuant to Rule 30e-1 under the Investment Company Act of 1940, as amended (the “1940 Act”): |
GMO Ultra-Short Income ETF

Ticker: GMOC; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO Ultra-Short Income ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO Ultra-Short Income ETF |
$10 |
0.20%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$32,528,978 |
|---|---|
Number of Portfolio Holdings |
59 |
Portfolio Turnover Rate |
87% |
What does the Fund invest in?
Asset Class Summary
% of Total Net Assets
Debt Obligations |
96.6 |
|---|---|
Short-Term Investments |
3.2 |
Other |
0.2 |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO Domestic Resilience ETF

Ticker: DRES; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO Domestic Resilience ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO Domestic Resilience ETF |
$25 |
0.50%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$36,426,148 |
|---|---|
Number of Portfolio Holdings |
39 |
Portfolio Turnover Rate |
1% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Capital Goods |
49.5 |
|---|---|
Transportation |
17.8 |
Materials |
15.9 |
Energy |
12.0 |
Software & Services |
2.7 |
Commercial & Professional Services |
2.1 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO Dynamic Allocation ETF

Ticker: GMOD; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO Dynamic Allocation ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO Dynamic Allocation ETF |
$12Footnote Reference1 |
0.24%Footnote Reference1,Footnote Reference2 |
| Footnote | Description |
Footnote1 |
The costs do not reflect fees and expenses of underlying funds. Those fees and expenses are material and, if reflected, the costs in the table would be higher. Please refer to the prospectus for more information about the fees and expenses of an investment in the Fund, including fees and expenses of underlying funds in which the Fund invests. |
Footnote2 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$45,390,595 |
|---|---|
Number of Portfolio Holdings |
19 |
Portfolio Turnover Rate |
20% |
What does the Fund invest in?
Asset Class Summary
% of Total Net Assets
Fixed Income Funds |
40.8 |
|---|---|
International Equity Funds |
25.5 |
U.S. Equity Funds |
25.3 |
Emerging Equity Funds |
7.8 |
Short-Term Investments |
0.6 |
Top Ten HoldingsFootnote Reference*
% of Investments
Schwab U.S. TIPS ETF |
10.3 |
|---|---|
GMO U.S. Quality ETF |
10.3 |
GMO U.S. Value ETF |
10.2 |
GMO International Value ETF |
10.1 |
Schwab Intermediate-Term U.S. Treasury ETF |
7.8 |
Vanguard Intermediate-Term Treasury ETF |
7.8 |
State Street SPDR Portfolio Intermediate Term Treasury ETF |
6.6 |
iShares 3-7 Year Treasury Bond ETF |
5.8 |
GMO International Quality ETF |
5.2 |
iShares Core MSCI Emerging Markets ETF |
5.0 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO International Quality ETF

Ticker: QLTI; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO International Quality ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO International Quality ETF |
$30 |
0.60%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$297,075,663 |
|---|---|
Number of Portfolio Holdings |
37 |
Portfolio Turnover Rate |
13% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Capital Goods |
14.7 |
|---|---|
Semiconductors & Semiconductor Equipment |
10.7 |
Pharmaceuticals, Biotechnology & Life Sciences |
10.6 |
Food, Beverage & Tobacco |
10.6 |
Software & Services |
9.9 |
Materials |
8.5 |
Household & Personal Products |
8.0 |
Consumer Services |
7.1 |
Consumer Discretionary Distribution & Retail |
5.3 |
Commercial & Professional Services |
5.2 |
Health Care Equipment & Services |
4.0 |
Transportation |
2.8 |
Consumer Durables & Apparel |
2.6 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Country/Region SummaryFootnote Reference**
% of Investments
France |
22.8 |
|---|---|
United Kingdom |
13.9 |
Spain |
9.2 |
Switzerland |
9.1 |
Germany |
7.9 |
Japan |
7.2 |
Ireland |
6.6 |
Taiwan |
5.3 |
Netherlands |
3.9 |
Australia |
3.0 |
Sweden |
2.9 |
Finland |
2.3 |
Mexico |
2.2 |
Italy |
1.9 |
Canada |
1.8 |
| Footnote | Description |
Footnote** |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO International Value ETF

Ticker: GMOI; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO International Value ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO International Value ETF |
$32 |
0.60%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$691,287,434 |
|---|---|
Number of Portfolio Holdings |
174 |
Portfolio Turnover Rate |
9% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Banks |
21.5 |
|---|---|
Energy |
10.7 |
Pharmaceuticals, Biotechnology & Life Sciences |
10.3 |
Insurance |
9.3 |
Automobiles & Components |
8.2 |
Materials |
7.1 |
Telecommunication Services |
5.9 |
Financial Services |
5.5 |
Capital Goods |
5.1 |
Food, Beverage & Tobacco |
3.6 |
Transportation |
2.3 |
Real Estate Management & Development |
2.1 |
Technology Hardware & Equipment |
1.7 |
Consumer Staples Distribution & Retail |
1.7 |
Consumer Durables & Apparel |
1.2 |
Other (each less than 1%) |
3.8 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Country/Region SummaryFootnote Reference**
% of Investments
Japan |
21.8 |
|---|---|
Canada |
14.3 |
United Kingdom |
11.6 |
France |
11.1 |
Germany |
9.4 |
Spain |
6.6 |
Switzerland |
6.0 |
Australia |
3.4 |
Netherlands |
2.7 |
Norway |
2.3 |
Hong Kong |
2.2 |
Italy |
2.0 |
Israel |
1.6 |
Sweden |
1.2 |
Austria |
1.2 |
Other (each less than 1%) |
2.6 |
| Footnote | Description |
Footnote** |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO Power Infrastructure ETF

Ticker: KWH; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO Power Infrastructure ETF for the period of July 14, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last period?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investmentFootnote Reference* |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO Power Infrastructure ETF |
$8 |
0.60%Footnote Reference1 |
| Footnote | Description |
Footnote* |
For the period July 14, 2026 (commencement of operations) through August 31, 2026. The costs would have been higher had the Fund operated the full six-month period. |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$57,536,066 |
|---|---|
Number of Portfolio Holdings |
75 |
Portfolio Turnover Rate |
5% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Capital Goods |
42.8 |
|---|---|
Utilities |
34.1 |
Energy |
12.0 |
Materials |
5.2 |
Technology Hardware & Equipment |
3.3 |
Semiconductors & Semiconductor Equipment |
1.6 |
Food, Beverage & Tobacco |
1.0 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Country/Region SummaryFootnote Reference**
% of Investments
United States |
52.5 |
|---|---|
Germany |
8.6 |
France |
6.7 |
United Kingdom |
5.2 |
South Korea |
4.6 |
Italy |
3.9 |
Switzerland |
3.1 |
China |
2.7 |
Spain |
2.5 |
Denmark |
2.5 |
Canada |
2.2 |
Japan |
1.5 |
Finland |
1.2 |
Other (each less than 1%) |
2.8 |
| Footnote | Description |
Footnote** |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO Systematic Investment Grade Credit ETF

Ticker: INVG; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO Systematic Investment Grade Credit ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO Systematic Investment Grade Credit ETF |
$13 |
0.25%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$23,631,326 |
|---|---|
Number of Portfolio Holdings |
128 |
Portfolio Turnover Rate |
65% |
What does the Fund invest in?
The Fund primarily invested in debt securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Banks |
14.4 |
|---|---|
Energy |
11.9 |
Semiconductors & Semiconductor Equipment |
11.2 |
Health Care Equipment & Services |
7.7 |
Equity Real Estate Investment Trusts (REITs) |
7.5 |
Financial Services |
6.7 |
Pharmaceuticals, Biotechnology & Life Sciences |
5.6 |
Technology Hardware & Equipment |
5.4 |
Capital Goods |
5.3 |
Utilities |
4.2 |
Food, Beverage & Tobacco |
3.5 |
Consumer Durables & Apparel |
3.4 |
Transportation |
3.3 |
Materials |
3.2 |
Consumer Services |
3.0 |
Telecommunication Services |
2.4 |
Insurance |
1.0 |
Other (each less than 1%) |
0.3 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Country/Region SummaryFootnote Reference**
% of Investments
United States |
82.0 |
|---|---|
Canada |
9.6 |
United Kingdom |
7.0 |
Other (each less than 1%) |
1.4 |
| Footnote | Description |
Footnote** |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO U.S. Value ETF

Ticker: GMOV; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO U.S. Value ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO U.S. Value ETF |
$27 |
0.50%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$107,052,929 |
|---|---|
Number of Portfolio Holdings |
163 |
Portfolio Turnover Rate |
19% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Pharmaceuticals, Biotechnology & Life Sciences |
11.6 |
|---|---|
Software & Services |
10.5 |
Banks |
10.1 |
Energy |
9.0 |
Insurance |
7.2 |
Media & Entertainment |
6.6 |
Financial Services |
6.4 |
Health Care Equipment & Services |
6.3 |
Telecommunication Services |
4.7 |
Consumer Discretionary Distribution & Retail |
3.2 |
Household & Personal Products |
2.7 |
Food, Beverage & Tobacco |
2.7 |
Semiconductors & Semiconductor Equipment |
2.3 |
Consumer Durables & Apparel |
2.3 |
Consumer Staples Distribution & Retail |
2.2 |
Commercial & Professional Services |
2.1 |
Automobiles & Components |
2.0 |
Transportation |
1.7 |
Capital Goods |
1.6 |
Technology Hardware & Equipment |
1.6 |
Materials |
1.4 |
Other (each less than 1%) |
1.8 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
GMO U.S. Quality ETF

Ticker: QLTY; Exchange: NYSE Arca, Inc.
Semi-Annual Shareholder Report - August 31, 2026
This semi-annual shareholder report contains important information about GMO U.S. Quality ETF for the period of March 1, 2026 to August 31, 2026. You can find additional information about the Fund at https://www.gmo.com/americas/etf-documents/. You can also request this information by contacting us at (844) 761-1102 (toll-free).
What were the Fund costs for the last six months?
(based on a hypothetical $10,000 investment)
Fund Name |
Costs of a $10,000 investment |
Costs paid as a percentage of a $10,000 investment |
|---|---|---|
GMO U.S. Quality ETF |
$27 |
0.50%Footnote Reference1 |
| Footnote | Description |
Footnote1 |
Annualized. |
Key Fund Statistics
Total Net Assets |
$5,178,618,870 |
|---|---|
Number of Portfolio Holdings |
44 |
Portfolio Turnover Rate |
11% |
What does the Fund invest in?
The Fund primarily invested in equity securities at period end.
Industry Group SummaryFootnote Reference*
% of Investments
Software & Services |
16.3 |
|---|---|
Semiconductors & Semiconductor Equipment |
16.0 |
Pharmaceuticals, Biotechnology & Life Sciences |
12.7 |
Media & Entertainment |
11.2 |
Health Care Equipment & Services |
11.1 |
Financial Services |
7.1 |
Food, Beverage & Tobacco |
5.1 |
Consumer Discretionary Distribution & Retail |
4.9 |
Technology Hardware & Equipment |
4.6 |
Consumer Services |
4.0 |
Household & Personal Products |
2.0 |
Banks |
1.9 |
Capital Goods |
1.8 |
Transportation |
1.3 |
| Footnote | Description |
Footnote* |
Excludes short-term investments and derivative financial instruments, if any. |
Additional Information

For additional information about the Fund, including the Fund's prospectus, financial statements, quarterly portfolio holdings and proxy voting information, please visit https://www.gmo.com/americas/etf-documents/ or scan the QR code.
Phone: (844) 761-1102 (toll-free)
| (b) | Not applicable. |
Item 2. Code of Ethics.
Not applicable for semi-annual reports.
Item 3. Audit Committee Financial Expert.
Not applicable for semi-annual reports.
Item 4. Principal Accountant Fees and Services.
Not applicable for semi-annual reports.
Item 5. Audit Committee of Listed Registrants.
Not applicable for semi-annual reports.
Item 6. Investments.
| (a) | The Schedule of Investments is included as part of the Financial Statements filed under Item 7(a) of this Form. |
| (b) | Not applicable. |
Item 7. Financial Statements and Financial Highlights for Open-End Management Investment Companies.
| (a) | The registrant’s Financial Statements are attached herewith. |
| (b) | The registrant’s Financial Highlights are included as part of the Financial Statements filed under Item 7(a) of this Form. |
Semi-Annual Financial Statements and Other Information
August 31, 2026
| Domestic Resilience ETF |
| Dynamic Allocation ETF |
| International Quality ETF |
| International Value ETF |
| Power Infrastructure ETF |
| Systematic Investment Grade Credit ETF |
| U.S. Quality ETF |
| U.S. Value ETF |
| Ultra-Short Income ETF |
For a free copy of the Funds’ proxy voting guidelines, shareholders may call 1-844 761-1102 (toll-free), visit GMO's website at www.gmo.com, or visit the Securities and Exchange Commission’s website at www.sec.gov. Information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 will be available without charge on GMO’s website at www.gmo.com and on the Securities and Exchange Commission’s website at www.sec.gov no later than August 31 of each year.
The Funds file their complete schedule of portfolio holdings with the Securities and Exchange Commission for the first and third quarter of each fiscal year on Form N-PORT, which is available on the Commission’s website at www.sec.gov or at www.gmo.com.
Information regarding how often shares of the Funds are traded on the New York Stock Exchange at a price above (i.e., at a premium) or below (i.e., at a discount) the NAV of the Funds can be found at www.gmo.com.
This report is prepared for the general information of shareholders. It is authorized for distribution to prospective investors only when preceded or accompanied by a prospectus for GMO ETF Trust which contains a complete discussion of the risks associated with an investment in these Funds and other important information. GMO ETF Trust prospectus can be obtained at www.gmo.com or by calling 1-844 761-1102 (toll-free). GMO ETF Trust Statement of Additional Information includes additional information about the Trustees of GMO ETF Trust and is available without charge, upon request, by calling 1-844 761-1102 (toll-free).
An investment in the Funds is subject to risk, including the possible loss of principal amount invested. There can be no assurance that the Funds will achieve their stated investment objectives. Please see the Funds’ prospectus regarding specific principal risks for each Fund. General risks may include: market risk-equities, management and operational risk, focused investment risk, ETF risks, limited authorized participants, market makers and liquidity providers risk, new/smaller funds risk and market disruption.
| 1 | |
| 2 | |
| 3 | |
| 4 | |
| 7 | |
| 9 | |
| 12 | |
| 14 | |
| 17 | |
| 19 | |
| 20 | |
| 23 | |
| 26 | |
| 31 | |
| 40 | |
| 56 |
GMO Domestic Resilience ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 99.5% | ||
| Capital Goods — 49.3% | ||
| 2,897 |
Acuity, Inc. |
961,196 |
| 14,515 |
AECOM |
978,746 |
| 8,255 |
Allegion PLC |
1,281,589 |
| 2,104 |
Applied Industrial Technologies, Inc. |
681,654 |
| 3,441 |
Carlisle Cos., Inc. |
1,192,582 |
| 3,205 |
Ferguson Enterprises, Inc. |
719,555 |
| 23,637 |
Fluor Corp. * |
1,288,453 |
| 750 |
Hubbell, Inc. |
339,750 |
| 3,867 |
Huntington Ingalls Industries, Inc. |
1,126,070 |
| 10,548 |
Jacobs Solutions, Inc. |
1,572,179 |
| 2,756 |
L3Harris Technologies, Inc. |
733,785 |
| 1,388 |
Lockheed Martin Corp. |
778,987 |
| 1,124 |
MYR Group, Inc. * |
327,556 |
| 2,399 |
Northrop Grumman Corp. |
1,294,740 |
| 6,265 |
Regal Rexnord Corp. |
992,689 |
| 2,158 |
Rockwell Automation, Inc. |
915,920 |
| 890 |
United Rentals, Inc. |
923,820 |
| 2,137 |
WESCO International, Inc. |
727,435 |
| 53,077 |
WillScot Holdings Corp. |
1,098,694 |
| Total Capital Goods |
17,935,400 | |
| Commercial & Professional Services — 2.1% | ||
| 2,464 |
Clean Harbors, Inc. * |
776,776 |
| Energy — 11.9% | ||
| 11,141 |
ConocoPhillips |
1,476,071 |
| 6,328 |
EOG Resources, Inc. |
917,307 |
| 24,102 |
EQT Corp. |
1,305,846 |
| 6,585 |
Expand Energy Corp. |
646,384 |
| Total Energy |
4,345,608 | |
| Materials — 15.9% | ||
| 20,033 |
Amrize Ltd. * |
875,442 |
| 5,266 |
Eagle Materials, Inc. |
1,022,973 |
| 2,802 |
Martin Marietta Materials, Inc. |
1,453,397 |
| 3,198 |
Nucor Corp. |
798,349 |
| 1,651 |
Steel Dynamics, Inc. |
384,056 |
| 4,582 |
Vulcan Materials Co. |
1,235,216 |
| Total Materials |
5,769,433 | |
| Software & Services — 2.7% | ||
| 2,312 |
Roper Technologies, Inc. |
981,768 |
| Transportation — 17.6% | ||
| 4,896 |
CH Robinson Worldwide, Inc. |
732,735 |
| 17,588 |
CSX Corp. |
888,370 |
| 11,801 |
Knight-Swift Transportation Holdings, Inc. |
808,487 |
| 3,430 |
Old Dominion Freight Line, Inc. |
685,863 |
| 1,185 |
Saia, Inc. * |
420,829 |
| 3,705 |
TFI International, Inc. |
497,174 |
| Shares |
Description |
Value ($) |
| Transportation — continued | ||
| 7,923 |
Union Pacific Corp. |
2,382,208 |
| Total Transportation |
6,415,666 | |
| TOTAL COMMON STOCKS (COST $33,873,464) |
36,224,651 | |
| SHORT-TERM INVESTMENTS — 0.4% | ||
| Money Market Funds — 0.4% | ||
| 155,859 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (a) |
155,859 |
| TOTAL SHORT-TERM INVESTMENTS (COST $155,859) |
155,859 | |
| TOTAL INVESTMENTS — 99.9% (Cost $34,029,323) |
36,380,510 | |
| Other Assets and Liabilities (net) — 0.1% |
45,638 | |
| TOTAL NET ASSETS — 100.0% |
$36,426,148 | |
| Notes to Schedule of Investments: | |
| * |
Non-income producing security. |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
1
GMO Dynamic Allocation ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| INVESTMENT FUNDS — 99.4% | ||
| United States — 99.4% | ||
| 44,495 |
GMO Domestic Resilience ETF (a) |
1,351,406 |
| 84,036 |
GMO International Quality ETF (a) |
2,332,243 |
| 110,734 |
GMO International Value ETF (a) |
4,567,777 |
| 35,402 |
GMO Power Infrastructure ETF (a) |
877,453 |
| 108,045 |
GMO U.S. Quality ETF (a) |
4,653,498 |
| 140,944 |
GMO U.S. Value ETF (a) |
4,603,104 |
| 22,677 |
iShares 3-7 Year Treasury Bond ETF |
2,634,387 |
| 27,540 |
iShares Core MSCI Emerging Markets ETF |
2,250,844 |
| 14,894 |
iShares Core MSCI International Developed Markets ETF |
1,379,631 |
| 10,519 |
iShares MSCI EAFE Small-Cap ETF |
913,049 |
| 13,158 |
iShares MSCI Emerging Markets ex China ETF |
1,292,642 |
| 38,652 |
iShares MSCI Japan Value ETF |
1,843,314 |
| 143,890 |
Schwab Intermediate-Term U.S. Treasury ETF |
3,502,283 |
| 179,915 |
Schwab U.S. TIPS ETF |
4,661,598 |
| 106,311 |
State Street SPDR Portfolio Intermediate Term Treasury ETF |
2,977,771 |
| 60,158 |
Vanguard Intermediate-Term Treasury ETF |
3,501,797 |
| 21,346 |
Vanguard Short-Term Treasury ETF |
1,239,349 |
| 6,096 |
Vanguard Total International Stock ETF |
532,303 |
| TOTAL INVESTMENT FUNDS (COST $42,669,485) |
45,114,449 | |
| SHORT-TERM INVESTMENTS — 0.6% | ||
| Money Market Funds — 0.6% | ||
| 284,097 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (b) |
284,097 |
| TOTAL SHORT-TERM INVESTMENTS (COST $284,097) |
284,097 | |
| TOTAL INVESTMENTS — 100.0% (Cost $42,953,582) |
45,398,546 | |
| Other Assets and Liabilities (net) — (0.0%) |
(7,951 ) | |
| TOTAL NET ASSETS — 100.0% |
$45,390,595 | |
| Notes to Schedule of Investments: | |
| (a) |
Affiliated company (Note 8). |
| (b) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
2
GMO International Quality ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 99.2% | ||
| Capital Goods — 14.5% | ||
| 231,651 |
Assa Abloy AB – Class B |
8,639,461 |
| 76,066 |
Knorr-Bremse AG |
9,330,227 |
| 111,568 |
Kone OYJ – Class B |
6,839,853 |
| 115,951 |
Safran SA ADR |
11,277,394 |
| 103,488 |
Schneider Electric SE ADR |
7,076,509 |
| Total Capital Goods |
43,163,444 | |
| Commercial & Professional Services — 5.2% | ||
| 624,252 |
Brambles Ltd. |
8,763,368 |
| 159,451 |
Experian PLC Sponsored ADR |
6,555,031 |
| Total Commercial & Professional Services |
15,318,399 | |
| Consumer Discretionary Distribution & Retail — 5.3% | ||
| 232,390 |
Industria de Diseno Textil SA |
15,656,084 |
| Consumer Durables & Apparel — 2.6% | ||
| 73,516 |
LVMH Moet Hennessy Louis Vuitton SE ADR |
7,710,358 |
| Consumer Services — 7.0% | ||
| 168,888 |
Amadeus IT Group SA |
11,421,120 |
| 312,218 |
Compass Group PLC Sponsored ADR |
9,503,916 |
| Total Consumer Services |
20,925,036 | |
| Food, Beverage & Tobacco — 10.5% | ||
| 823,019 |
Davide Campari-Milano NV |
5,563,788 |
| 85,150 |
Diageo PLC Sponsored ADR |
7,821,027 |
| 52,852 |
Fomento Economico Mexicano SAB de CV Sponsored ADR |
6,363,909 |
| 116,550 |
Kerry Group PLC – Class A |
11,371,802 |
| Total Food, Beverage & Tobacco |
31,120,526 | |
| Health Care Equipment & Services — 4.0% | ||
| 31,667 |
BioMerieux |
2,760,548 |
| 27,510 |
EssilorLuxottica SA ADR |
2,553,891 |
| 42,800 |
Hoya Corp. |
6,590,798 |
| Total Health Care Equipment & Services |
11,905,237 | |
| Household & Personal Products — 7.9% | ||
| 125,826 |
L'Oreal SA ADR |
11,219,905 |
| 189,439 |
Unilever PLC Sponsored ADR |
12,285,119 |
| Total Household & Personal Products |
23,505,024 | |
| Materials — 8.5% | ||
| 277,943 |
Air Liquide SA ADR |
10,923,160 |
| 405,100 |
Nippon Paint Holdings Co. Ltd. |
3,064,559 |
| 374,106 |
Shin-Etsu Chemical Co. Ltd. ADR |
7,003,265 |
| 17,645 |
Sika AG (Registered) |
4,192,147 |
| Total Materials |
25,183,131 | |
| Shares |
Description |
Value ($) |
| Pharmaceuticals, Biotechnology & Life Sciences — 10.5% | ||
| 488,236 |
Haleon PLC ADR |
4,897,007 |
| 75,768 |
Novartis AG Sponsored ADR |
11,521,282 |
| 205,407 |
Roche Holding AG Sponsored ADR |
11,030,356 |
| 16,903 |
Sartorius Stedim Biotech |
3,848,199 |
| Total Pharmaceuticals, Biotechnology & Life Sciences |
31,296,844 | |
| Semiconductors & Semiconductor Equipment — 10.6% | ||
| 6,690 |
ASML Holding NV (Registered) |
11,346,307 |
| 37,807 |
Taiwan Semiconductor Manufacturing Co. Ltd. Sponsored ADR |
15,702,003 |
| 12,800 |
Tokyo Electron Ltd. |
4,522,266 |
| Total Semiconductors & Semiconductor Equipment |
31,570,576 | |
| Software & Services — 9.8% | ||
| 17,209 |
Capgemini SE |
2,143,831 |
| 2,367 |
Constellation Software, Inc. |
5,360,475 |
| 290,685 |
Dassault Systemes SE |
7,711,812 |
| 63,241 |
SAP SE Sponsored ADR |
13,969,305 |
| Total Software & Services |
29,185,423 | |
| Transportation — 2.8% | ||
| 147,605 |
Ryanair Holdings PLC Sponsored ADR |
8,172,889 |
| TOTAL COMMON STOCKS (COST $275,271,513) |
294,712,971 | |
| SHORT-TERM INVESTMENTS — 0.8% | ||
| Money Market Funds — 0.8% | ||
| 2,377,996 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (a) |
2,377,996 |
| TOTAL SHORT-TERM INVESTMENTS (COST $2,377,996) |
2,377,996 | |
| TOTAL INVESTMENTS — 100.0% (Cost $277,649,509) |
297,090,967 | |
| Other Assets and Liabilities (net) — (0.0)% |
(15,304 ) | |
| TOTAL NET ASSETS — 100.0% |
$297,075,663 | |
| Notes to Schedule of Investments: | |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
3
GMO International Value ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 98.4% | ||
| Australia — 3.3% | ||
| 130,957 |
BHP Group Ltd. Sponsored ADR |
12,299,481 |
| 474,008 |
Fortescue Ltd. |
6,012,231 |
| 71,931 |
QBE Insurance Group Ltd. |
1,147,408 |
| 10,813 |
Rio Tinto Ltd. |
1,354,532 |
| 111,860 |
Santos Ltd. |
652,493 |
| 67,651 |
Woodside Energy Group Ltd. ADR |
1,574,915 |
| Total Australia |
23,041,060 | |
| Austria — 1.2% | ||
| 58,546 |
OMV AG |
4,658,279 |
| 47,428 |
Raiffeisen Bank International AG |
3,514,740 |
| Total Austria |
8,173,019 | |
| Belgium — 0.3% | ||
| 27,248 |
Ageas SA |
2,389,568 |
| Canada — 14.2% | ||
| 39,676 |
Alimentation Couche-Tard, Inc. |
2,389,520 |
| 27,253 |
Bank of Montreal |
4,645,369 |
| 250,698 |
Bank of Nova Scotia |
22,978,979 |
| 24,178 |
BCE, Inc. |
570,359 |
| 4,755 |
Canadian Imperial Bank of Commerce |
539,788 |
| 12,386 |
Canadian Natural Resources Ltd. |
620,167 |
| 59,417 |
Cenovus Energy, Inc. |
1,910,256 |
| 3,348 |
Fairfax Financial Holdings Ltd. |
5,443,083 |
| 5,710 |
IGM Financial, Inc. |
355,508 |
| 67,251 |
Magna International, Inc. |
4,409,648 |
| 327,658 |
Manulife Financial Corp. |
13,895,976 |
| 42,432 |
Nutrien Ltd. |
3,204,889 |
| 40,444 |
Open Text Corp. |
1,008,269 |
| 84,028 |
Parex Resources, Inc. |
1,729,123 |
| 30,754 |
Power Corp. of Canada |
2,037,914 |
| 47,895 |
Rogers Communications, Inc. – Class B |
1,766,926 |
| 172,799 |
Sun Life Financial, Inc. |
13,543,986 |
| 25,717 |
Suncor Energy, Inc. |
1,718,410 |
| 128,604 |
Toronto-Dominion Bank |
15,558,305 |
| Total Canada |
98,326,475 | |
| Denmark — 0.8% | ||
| 622 |
AP Moller - Maersk AS – Class A |
2,012,298 |
| 928 |
AP Moller - Maersk AS – Class B |
3,106,095 |
| 69,120 |
H Lundbeck AS |
453,249 |
| Total Denmark |
5,571,642 | |
| Finland — 0.3% | ||
| 53,254 |
Valmet OYJ |
1,774,063 |
| France — 11.0% | ||
| 81,502 |
AXA SA |
4,080,217 |
| 187,697 |
BNP Paribas SA |
22,408,029 |
| 22,076 |
Capgemini SE |
2,750,144 |
| Shares |
Description |
Value ($) |
| France — continued | ||
| 434,143 |
Sanofi SA ADR |
19,258,583 |
| 13,201 |
Teleperformance SE |
1,068,753 |
| 273,850 |
TotalEnergies SE |
24,183,693 |
| 149,325 |
Valeo SE |
2,495,922 |
| Total France |
76,245,341 | |
| Germany — 8.6% | ||
| 14,406 |
Allianz SE (Registered) |
7,543,363 |
| 20,544 |
Bayerische Motoren Werke AG |
1,479,021 |
| 33,931 |
Daimler Truck Holding AG |
1,844,113 |
| 432,160 |
Deutsche Bank AG (Registered) |
17,398,461 |
| 51,944 |
Deutsche Post AG |
3,387,236 |
| 413,584 |
Deutsche Telekom AG Sponsored ADR |
13,673,087 |
| 12,670 |
DWS Group GmbH & Co. KGaA |
1,114,800 |
| 18,080 |
Fresenius Medical Care AG |
828,482 |
| 18,452 |
Henkel AG & Co. KGaA |
1,512,092 |
| 127,647 |
Mercedes-Benz Group AG |
7,001,229 |
| 7,719 |
Merck KGaA |
1,246,274 |
| 2,675 |
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen (Registered) |
1,611,987 |
| 11,983 |
Traton SE |
534,762 |
| Total Germany |
59,174,907 | |
| Hong Kong — 2.1% | ||
| 389,500 |
CK Asset Holdings Ltd. |
2,251,000 |
| 620,000 |
CK Hutchison Holdings Ltd. |
5,576,357 |
| 110,500 |
Kerry Properties Ltd. |
260,093 |
| 334,000 |
Sun Hung Kai Properties Ltd. |
4,951,336 |
| 1,950,000 |
WH Group Ltd. |
1,844,657 |
| Total Hong Kong |
14,883,443 | |
| Ireland — 0.3% | ||
| 188,702 |
AIB Group PLC |
2,403,382 |
| Israel — 1.6% | ||
| 140,244 |
Bank Hapoalim BM |
3,623,421 |
| 76,497 |
Bank Leumi Le-Israel BM |
1,952,369 |
| 4,694 |
First International Bank of Israel Ltd. |
369,246 |
| 104,281 |
ICL Group Ltd. |
596,051 |
| 128,007 |
Israel Discount Bank Ltd. – Class A |
1,464,185 |
| 25,384 |
Mizrahi Tefahot Bank Ltd. |
1,968,779 |
| 39,582 |
ZIM Integrated Shipping Services Ltd. |
1,084,547 |
| Total Israel |
11,058,598 | |
| Italy — 2.0% | ||
| 199,045 |
Banco BPM SpA |
3,717,706 |
| 14,179 |
Buzzi SpA |
676,242 |
| 127,352 |
Hera SpA |
563,893 |
| 112,299 |
Intesa Sanpaolo SpA |
885,563 |
| 215,644 |
MFE-MediaForEurope NV – Class A |
645,239 |
| 161,431 |
Pirelli & C SpA |
1,247,880 |
| 75,929 |
Telecom Italia SpA * |
691,098 |
See accompanying notes to the financial statements.
4
GMO International Value ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| Italy — continued | ||
| 155,872 |
Unipol Assicurazioni SpA |
5,109,317 |
| Total Italy |
13,536,938 | |
| Japan — 21.6% | ||
| 370,900 |
Asahi Group Holdings Ltd. |
3,891,258 |
| 100,800 |
Astellas Pharma, Inc. |
1,496,383 |
| 79,400 |
Bridgestone Corp. |
2,060,175 |
| 61,200 |
Brother Industries Ltd. |
1,879,482 |
| 155,900 |
Canon, Inc. |
4,562,332 |
| 7,400 |
Credit Saison Co. Ltd. |
216,372 |
| 105,700 |
Daito Trust Construction Co. Ltd. |
2,203,324 |
| 154,200 |
Daiwa House Industry Co. Ltd. |
4,517,408 |
| 542,300 |
Denso Corp. |
6,568,704 |
| 10,300 |
Electric Power Development Co. Ltd. – Class C |
263,964 |
| 110,500 |
ENEOS Holdings, Inc. |
926,194 |
| 45,700 |
FUJIFILM Holdings Corp. |
969,784 |
| 45,400 |
Hitachi Construction Machinery Co. Ltd. |
1,629,853 |
| 476,673 |
Honda Motor Co. Ltd. Sponsored ADR |
15,234,469 |
| 339,700 |
Inpex Corp. |
8,414,353 |
| 62,400 |
Isuzu Motors Ltd. |
893,326 |
| 174,300 |
ITOCHU Corp. |
2,299,996 |
| 335,900 |
Japan Post Holdings Co. Ltd. |
5,228,265 |
| 175,100 |
Kirin Holdings Co. Ltd. |
3,347,452 |
| 163,100 |
Kobe Steel Ltd. |
2,062,360 |
| 172,800 |
Komatsu Ltd. |
8,045,611 |
| 221,053 |
Kubota Corp. |
4,057,827 |
| 55,700 |
Mazda Motor Corp. |
429,561 |
| 270,300 |
Mitsui & Co. Ltd. |
8,475,322 |
| 60,400 |
MS&AD Insurance Group Holdings, Inc. |
1,930,910 |
| 125,000 |
Nippon Yusen KK |
5,508,607 |
| 19,900 |
Nitto Denko Corp. |
437,489 |
| 16,067,200 |
NTT, Inc. |
17,349,559 |
| 130,500 |
Ono Pharmaceutical Co. Ltd. |
2,001,817 |
| 18,000 |
Otsuka Holdings Co. Ltd. |
1,380,282 |
| 237,100 |
Persol Holdings Co. Ltd. |
447,039 |
| 133,200 |
Ricoh Co. Ltd. |
1,415,380 |
| 23,000 |
Rohto Pharmaceutical Co. Ltd. |
439,844 |
| 70,500 |
Seiko Epson Corp. |
1,425,005 |
| 136,400 |
Sekisui Chemical Co. Ltd. |
2,266,930 |
| 128,900 |
Sekisui House Ltd. |
2,780,528 |
| 123,000 |
Shionogi & Co. Ltd. |
2,240,948 |
| 137,595 |
Sony Group Corp. Sponsored ADR |
3,379,333 |
| 39,400 |
Subaru Corp. |
658,023 |
| 62,600 |
Sumitomo Corp. |
702,021 |
| 203,500 |
Sumitomo Forestry Co. Ltd. |
1,713,986 |
| 57,600 |
Suntory Beverage & Food Ltd. |
1,626,862 |
| 187,500 |
Suzuki Motor Corp. |
2,613,850 |
| 25,200 |
Tosoh Corp. |
420,789 |
| 40,900 |
Toyo Tire Corp. |
964,446 |
| 42,269 |
Toyota Motor Corp. Sponsored ADR |
8,307,549 |
| Total Japan |
149,684,972 | |
| Shares |
Description |
Value ($) |
| Netherlands — 2.7% | ||
| 64,365 |
ABN AMRO Bank NV |
3,118,370 |
| 286,658 |
ING Groep NV Sponsored ADR |
10,124,761 |
| 97,705 |
Koninklijke Ahold Delhaize NV |
3,478,444 |
| 93,101 |
Signify NV |
1,664,296 |
| Total Netherlands |
18,385,871 | |
| Norway — 2.3% | ||
| 340,025 |
Equinor ASA Sponsored ADR |
14,553,070 |
| 41,920 |
Orkla ASA |
428,229 |
| 47,350 |
Wallenius Wilhelmsen ASA |
823,985 |
| Total Norway |
15,805,284 | |
| Singapore — 0.8% | ||
| 46,125 |
Hafnia Ltd. |
389,486 |
| 74,000 |
Oversea-Chinese Banking Corp. Ltd. |
1,835,009 |
| 88,100 |
United Overseas Bank Ltd. |
2,880,526 |
| 138,400 |
Wilmar International Ltd. |
418,107 |
| Total Singapore |
5,523,128 | |
| Spain — 6.5% | ||
| 787,630 |
Banco Bilbao Vizcaya Argentaria SA Sponsored ADR |
22,809,765 |
| 436,731 |
Banco de Sabadell SA |
1,842,965 |
| 828,024 |
Banco Santander SA |
12,180,119 |
| 20,423 |
Puig Brands SA – Class B |
437,440 |
| 246,698 |
Repsol SA |
7,808,540 |
| Total Spain |
45,078,829 | |
| Sweden — 1.2% | ||
| 30,757 |
Essity AB – Class B |
901,421 |
| 136,941 |
Husqvarna AB – Class B |
544,753 |
| 126,375 |
Investor AB – B Shares |
5,450,764 |
| 127,316 |
Telefonaktiebolaget LM Ericsson Sponsored ADR |
1,284,618 |
| Total Sweden |
8,181,556 | |
| Switzerland — 6.0% | ||
| 157,305 |
Adecco Group AG (Registered) |
4,682,079 |
| 101,721 |
Nestle SA Sponsored ADR |
9,892,367 |
| 66,369 |
Novartis AG Sponsored ADR |
10,092,070 |
| 27,888 |
Roche Holding AG |
12,171,567 |
| 3,711 |
Roche Holding AG – Class BR |
1,654,536 |
| 23,403 |
Sandoz Group AG ADR |
1,968,426 |
| 16,436 |
UBS Group AG (Registered) |
900,336 |
| Total Switzerland |
41,361,381 | |
| United Kingdom — 11.6% | ||
| 203,634 |
3i Group PLC |
7,803,137 |
| 327,280 |
Aberdeen Group PLC |
1,118,418 |
| 108,293 |
Associated British Foods PLC |
3,011,045 |
| 249,681 |
B&M European Value Retail PLC |
803,843 |
| 7,711 |
Berkeley Group Holdings PLC * |
373,008 |
See accompanying notes to the financial statements.
5
GMO International Value ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| United Kingdom — continued | ||
| 76,665 |
Big Yellow Group PLC – (REIT) |
911,557 |
| 2,188,176 |
BT Group PLC |
6,087,104 |
| 47,145 |
DCC Energy PLC |
4,069,252 |
| 56,550 |
Drax Group PLC |
593,846 |
| 314,596 |
GSK PLC Sponsored ADR |
15,808,449 |
| 47,218 |
Hikma Pharmaceuticals PLC |
1,033,924 |
| 38,209 |
HSBC Holdings PLC Sponsored ADR |
3,940,876 |
| 18,482 |
ICG PLC |
506,372 |
| 46,557 |
Inchcape PLC |
535,905 |
| 180,050 |
Investec PLC |
1,617,507 |
| 1,104,198 |
ITV PLC |
1,062,294 |
| 1,438,172 |
JD Sports Fashion PLC |
1,689,544 |
| 388,302 |
Kingfisher PLC |
1,660,002 |
| 6,900 |
Lion Finance Group PLC |
1,254,704 |
| 245,619 |
Man Group PLC |
1,028,395 |
| 5,047 |
Morgan Sindall Group PLC |
300,902 |
| 86,404 |
NatWest Group PLC Sponsored ADR |
1,572,553 |
| 212,675 |
Rio Tinto PLC Sponsored ADR |
21,799,187 |
| 76,949 |
RS Group PLC |
788,772 |
| 105,823 |
TP ICAP Group PLC |
494,409 |
| Total United Kingdom |
79,865,005 | |
| TOTAL COMMON STOCKS (COST $610,585,709) |
680,464,462 | |
| PREFERRED STOCKS (a) — 0.8% | ||
| Germany — 0.8% | ||
| 36,451 |
Henkel AG & Co. KGaA |
3,219,506 |
| 24,261 |
Volkswagen AG |
2,189,050 |
| Total Germany |
5,408,556 | |
| TOTAL PREFERRED STOCKS (COST $5,508,993) |
5,408,556 | |
| SHORT-TERM INVESTMENTS — 0.6% | ||
| Money Market Funds — 0.6% | ||
| 3,820,438 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (b) |
3,820,438 |
| TOTAL SHORT-TERM INVESTMENTS (COST $3,820,438) |
3,820,438 | |
| TOTAL INVESTMENTS — 99.8% (Cost $619,915,140) |
689,693,456 | |
| Other Assets and Liabilities (net) — 0.2% |
1,593,978 | |
| TOTAL NET ASSETS — 100.0% |
$691,287,434 | |
| Notes to Schedule of Investments: | |
| * |
Non-income producing security. |
| (a) |
Preferred dividend rates are disclosed to the extent that a stated rate exists. |
| (b) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
6
GMO Power Infrastructure ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 98.5% | ||
| Capital Goods — 42.6% | ||
| 12,933 |
ABB Ltd. (Registered) |
1,263,941 |
| 6,930 |
Ameresco, Inc. – Class A * |
153,292 |
| 69,700 |
Array Technologies, Inc. * |
308,074 |
| 9,810 |
Cadeler AS ADR * |
244,661 |
| 11,194 |
Carrier Global Corp. |
651,715 |
| 17,400 |
Contemporary Amperex Technology Co. Ltd. – Class H |
1,330,786 |
| 5,903 |
CS Wind Corp. |
210,914 |
| 2,727 |
Doosan Enerbility Co. Ltd. * |
164,385 |
| 4,917 |
Eaton Corp. PLC |
1,976,044 |
| 406 |
GE Vernova, Inc. |
364,803 |
| 174,400 |
Goldwind Science & Technology Co. Ltd. – Class H |
212,036 |
| 776 |
HD Hyundai Electric Co. Ltd. |
442,829 |
| 1,848 |
Hubbell, Inc. |
837,144 |
| 6,032 |
Johnson Controls International PLC |
833,864 |
| 3,034 |
LG Energy Solution Ltd. * |
837,975 |
| 638 |
MasTec, Inc. * |
152,980 |
| 34,800 |
Mitsubishi Heavy Industries Ltd. |
847,181 |
| 1,044 |
MYR Group, Inc. * |
304,242 |
| 5,454 |
Nexans SA |
883,745 |
| 9,096 |
Nextpower, Inc. – Class A * |
746,145 |
| 5,407 |
nVent Electric PLC |
815,105 |
| 2,842 |
Primoris Services Corp. |
204,937 |
| 5,509 |
Prysmian SpA |
769,157 |
| 638 |
Quanta Services, Inc. |
387,323 |
| 7,598 |
Rolls-Royce Holdings PLC Sponsored ADR |
154,315 |
| 8,645 |
Schneider Electric SE |
2,958,254 |
| 8,120 |
Siemens AG (Registered) |
2,693,717 |
| 2,668 |
Siemens Energy AG |
440,618 |
| 35,489 |
Sunrun, Inc. * |
304,141 |
| 3,480 |
Trane Technologies PLC |
1,546,512 |
| 43,384 |
Vestas Wind Systems AS |
1,441,313 |
| Total Capital Goods |
24,482,148 | |
| Energy — 11.9% | ||
| 15,080 |
Archrock, Inc. |
475,322 |
| 3,306 |
Cheniere Energy, Inc. |
964,327 |
| 20,706 |
EQT Corp. |
1,121,851 |
| 11,600 |
Expand Energy Corp. |
1,138,656 |
| 22,272 |
Kinder Morgan, Inc. |
718,049 |
| 18,560 |
Neste OYJ |
687,281 |
| 59,450 |
NexGen Energy Ltd. * |
621,974 |
| 41,586 |
Paladin Energy Ltd. * |
345,984 |
| 2,668 |
Targa Resources Corp. |
783,458 |
| Total Energy |
6,856,902 | |
| Food, Beverage & Tobacco — 1.0% | ||
| 8,990 |
Darling Ingredients, Inc. * |
595,767 |
| Shares |
Description |
Value ($) |
| Materials — 4.3% | ||
| 3,581 |
Albemarle Corp. |
483,327 |
| 2,263 |
Alcoa Corp. |
113,037 |
| 23,606 |
Anglo American PLC Sponsored ADR |
665,689 |
| 9,396 |
Freeport-McMoRan, Inc. |
711,653 |
| 2,136 |
Sika AG (Registered) |
507,477 |
| Total Materials |
2,481,183 | |
| Semiconductors & Semiconductor Equipment — 1.6% | ||
| 3,770 |
First Solar, Inc. * |
761,163 |
| 5,278 |
SolarEdge Technologies, Inc. * |
169,952 |
| Total Semiconductors & Semiconductor Equipment |
931,115 | |
| Technology Hardware & Equipment — 3.2% | ||
| 9,101 |
Itron, Inc. * |
882,888 |
| 2,325 |
Samsung SDI Co. Ltd. * |
980,217 |
| Total Technology Hardware & Equipment |
1,863,105 | |
| Utilities — 33.9% | ||
| 21,576 |
AES Corp. |
318,030 |
| 7,076 |
Alliant Energy Corp. |
481,027 |
| 7,656 |
American Electric Power Co., Inc. |
937,324 |
| 9,512 |
Consolidated Edison, Inc. |
1,017,974 |
| 9,454 |
Duke Energy Corp. |
1,133,629 |
| 53,360 |
E.ON SE |
1,103,249 |
| 87,638 |
EDP SA |
476,201 |
| 132,530 |
Enel SpA |
1,450,270 |
| 7,540 |
Entergy Corp. |
801,577 |
| 6,264 |
Evergy, Inc. |
507,509 |
| 24,186 |
Exelon Corp. |
1,057,412 |
| 12,992 |
FirstEnergy Corp. |
595,813 |
| 11,194 |
Fortis, Inc. |
618,600 |
| 61,944 |
Iberdrola SA |
1,444,777 |
| 17,748 |
National Grid PLC Sponsored ADR |
1,404,932 |
| 17,574 |
NextEra Energy, Inc. |
1,447,043 |
| 4,466 |
NRG Energy, Inc. |
491,796 |
| 17,516 |
PPL Corp. |
597,821 |
| 10,150 |
RWE AG |
691,350 |
| 7,980 |
Southern Co. |
702,240 |
| 23,490 |
SSE PLC Sponsored ADR |
773,996 |
| 4,582 |
Vistra Corp. |
629,429 |
| 10,672 |
Xcel Energy, Inc. |
807,764 |
| Total Utilities |
19,489,763 | |
| TOTAL COMMON STOCKS (COST $56,633,299) |
56,699,983 | |
See accompanying notes to the financial statements.
7
GMO Power Infrastructure ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| PREFERRED STOCKS (a) — 0.9% | ||
| Materials — 0.9% | ||
| 6,420 |
Sociedad Quimica y Minera de Chile SA Sponsored ADR |
507,244 |
| TOTAL PREFERRED STOCKS (COST $429,805) |
507,244 | |
| SHORT-TERM INVESTMENTS — 0.5% | ||
| Money Market Funds — 0.5% | ||
| 258,340 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (b) |
258,340 |
| TOTAL SHORT-TERM INVESTMENTS (COST $258,340) |
258,340 | |
| TOTAL INVESTMENTS — 99.9% (Cost $57,321,444) |
57,465,567 | |
| Other Assets and Liabilities (net) — 0.1% |
70,499 | |
| TOTAL NET ASSETS — 100.0% |
$57,536,066 | |
| Notes to Schedule of Investments: | |
| * |
Non-income producing security. |
| (a) |
Preferred dividend rates are disclosed to the extent that a stated rate exists. |
| (b) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
8
GMO Systematic Investment Grade Credit ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Par Value† |
Description |
Value ($) |
| DEBT OBLIGATIONS — 98.1% | ||
| Canada — 9.4% | ||
| Corporate Debt — 9.4% | ||
| 195,000 |
Bank of Montreal, Variable Rate, 1 day USD SOFR + 1.21%, 5.30%, due 06/02/37 |
190,522 |
| 60,000 |
Bank of Nova Scotia, Variable Rate, 1 day USD SOFR + 0.89%, 4.93%, due 02/14/29 |
60,129 |
| 168,000 |
Bank of Nova Scotia, Variable Rate, 1 day USD SOFR + 1.07%, 5.13%, due 02/14/31 |
168,041 |
| 235,000 |
Canadian Imperial Bank of Commerce, Variable Rate, 1 day USD SOFR + 1.34%, 4.63%, due 09/11/30 |
232,027 |
| 192,000 |
Canadian Imperial Bank of Commerce, Variable Rate, 1 day USD SOFR Index + 1.17%, 4.58%, due 09/08/31 |
188,065 |
| 225,000 |
Cenovus Energy, Inc., 5.40%, due 06/15/47 |
203,311 |
| 200,000 |
Royal Bank of Canada, Variable Rate, 1 day USD SOFR Index + 1.08%, 4.65%, due 10/18/30 |
197,882 |
| 105,000 |
Royal Bank of Canada, Variable Rate, 1 day USD SOFR + 1.03%, 5.15%, due 02/04/31 |
105,315 |
| 235,000 |
South Bow USA Infrastructure Holdings LLC, 5.58%, due 10/01/34 |
230,281 |
| 236,000 |
South Bow USA Infrastructure Holdings LLC, 6.18%, due 10/01/54 |
218,928 |
| 231,000 |
Toronto-Dominion Bank, 5.30%, due 01/30/32 |
232,517 |
| 206,000 |
Toronto-Dominion Bank, 3.20%, due 03/10/32 |
186,727 |
| Total Canada |
2,213,745 | |
| Japan — 0.8% | ||
| Corporate Debt — 0.8% | ||
| 205,000 |
Sumitomo Mitsui Financial Group, Inc., 3.04%, due 07/16/29 |
194,843 |
| Spain — 0.6% | ||
| Corporate Debt — 0.6% | ||
| 150,000 |
Telefonica Emisiones SA, 5.52%, due 03/01/49 |
132,375 |
| United Kingdom — 6.9% | ||
| Corporate Debt — 6.9% | ||
| 166,000 |
BAT Capital Corp., 7.08%, due 08/02/43 |
178,738 |
| 277,000 |
BAT Capital Corp., 4.54%, due 08/15/47 |
219,297 |
| 215,000 |
HSBC Holdings PLC, Variable Rate, 1 day USD SOFR + 1.56%, 5.45%, due 03/03/36 |
211,433 |
| 200,000 |
HSBC Holdings PLC, Variable Rate, 1 day USD SOFR + 1.88%, 5.79%, due 05/13/36 |
200,993 |
| 230,000 |
Marex U.K. Holdings Ltd., 6.40%, due 11/04/29 |
234,027 |
| 240,000 |
Marex U.K. Holdings Ltd., 5.68%, due 04/21/31 |
237,500 |
| 198,000 |
nVent Finance SARL, 5.65%, due 05/15/33 |
200,248 |
| Par Value† |
Description |
Value ($) |
| United Kingdom — continued | ||
| Corporate Debt — continued | ||
| 165,000 |
Vodafone Group PLC, 5.88%, due 06/28/64 |
149,303 |
| Total United Kingdom |
1,631,539 | |
| United States — 80.4% | ||
| Corporate Debt — 80.4% | ||
| 240,000 |
Advanced Micro Devices, Inc., 5.00%, due 08/17/31 |
238,138 |
| 240,000 |
Advanced Micro Devices, Inc., 5.25%, due 08/17/33 |
237,334 |
| 96,000 |
AEP Texas, Inc., 5.70%, due 05/15/34 |
96,934 |
| 240,000 |
Airbnb, Inc., 5.25%, due 03/16/36 |
234,775 |
| 312,000 |
Altria Group, Inc., 3.40%, due 02/04/41 |
230,240 |
| 269,000 |
Altria Group, Inc., 3.88%, due 09/16/46 |
191,840 |
| 235,000 |
American Assets Trust LP, 6.15%, due 10/01/34 |
233,459 |
| 235,000 |
Analog Devices, Inc., 4.25%, due 06/15/28 |
233,664 |
| 135,000 |
Analog Devices, Inc., 4.50%, due 06/15/30 |
133,429 |
| 230,000 |
Applied Materials, Inc., 1.75%, due 06/01/30 |
205,240 |
| 210,000 |
Applied Materials, Inc., 4.00%, due 01/15/31 |
202,522 |
| 56,000 |
Bank of New York Mellon Corp., Variable Rate, 1 day USD SOFR Index + 2.07%, 5.83%, due 10/25/33 |
57,756 |
| 166,000 |
Bank of New York Mellon Corp., Variable Rate, 1 day USD SOFR + 1.85%, 6.47%, due 10/25/34 |
176,774 |
| 280,000 |
Baxter International, Inc., 1.73%, due 04/01/31 |
237,737 |
| 275,000 |
Baxter International, Inc., 2.54%, due 02/01/32 |
236,296 |
| 230,000 |
BGC Group, Inc., 6.15%, due 04/02/30 |
232,330 |
| 198,000 |
Biogen, Inc., 6.45%, due 05/15/55 |
203,336 |
| 85,000 |
Bio-Rad Laboratories, Inc., 3.70%, due 03/15/32 |
78,463 |
| 13,000 |
BorgWarner, Inc., 4.95%, due 08/15/29 |
12,944 |
| 225,000 |
Boston Properties LP, 6.50%, due 01/15/34 |
234,392 |
| 75,000 |
Carrier Global Corp., 5.90%, due 03/15/34 |
77,372 |
| 224,000 |
Centene Corp., 2.45%, due 07/15/28 |
213,396 |
| 224,000 |
Centene Corp., 3.38%, due 02/15/30 |
208,005 |
| 125,000 |
CenterPoint Energy Houston Electric LLC, 5.05%, due 03/01/35 |
121,897 |
| 200,000 |
CH Robinson Worldwide, Inc., 4.20%, due 04/15/28 |
197,760 |
| 65,000 |
Cisco Systems, Inc., 5.50%, due 02/24/55 |
60,460 |
| 205,000 |
Cisco Systems, Inc., 5.35%, due 02/26/64 |
181,517 |
| 47,000 |
Citigroup, Inc., Variable Rate, 3 mo. USD Term SOFR + 1.65%, 3.67%, due 07/24/28 |
46,580 |
| 199,000 |
Citizens Financial Group, Inc., Variable Rate, 1 day USD SOFR + 1.91%, 5.72%, due 07/23/32 |
201,448 |
| 168,000 |
Citizens Financial Group, Inc., Variable Rate, 1 day USD SOFR + 2.33%, 6.65%, due 04/25/35 |
176,774 |
See accompanying notes to the financial statements.
9
GMO Systematic Investment Grade Credit ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Par Value† |
Description |
Value ($) |
| United States — continued | ||
| Corporate Debt — continued | ||
| 230,000 |
CNO Financial Group, Inc., 6.45%, due 06/15/34 |
235,186 |
| 170,000 |
CSX Corp., 4.30%, due 03/01/48 |
135,288 |
| 275,000 |
CSX Corp., 4.75%, due 11/15/48 |
232,887 |
| 198,000 |
Cummins, Inc., 5.30%, due 05/09/35 |
197,127 |
| 140,000 |
Dell International LLC/EMC Corp., 8.10%, due 07/15/36 |
162,496 |
| 180,000 |
Dell International LLC/EMC Corp., 8.35%, due 07/15/46 |
217,839 |
| 230,000 |
Diamondback Energy, Inc., 6.25%, due 03/15/53 |
231,991 |
| 195,000 |
Edison International, 6.95%, due 11/15/29 |
201,366 |
| 195,000 |
Edison International, 6.25%, due 03/15/30 |
196,816 |
| 200,000 |
Equitable Holdings, Inc., 5.00%, due 04/20/48 |
167,401 |
| 215,000 |
Flex Ltd., 5.38%, due 11/13/35 |
203,304 |
| 175,000 |
FNB Corp., Variable Rate, 1 day USD SOFR Index + 1.93%, 5.72%, due 12/11/30 |
175,450 |
| 120,000 |
Fortive Corp., 4.75%, due 05/15/31 |
117,419 |
| 197,000 |
Hasbro, Inc., 3.90%, due 11/19/29 |
190,470 |
| 182,000 |
Hasbro, Inc., 6.05%, due 05/14/34 |
187,283 |
| 100,000 |
Healthcare Realty Holdings LP, 2.00%, due 03/15/31 |
86,866 |
| 230,000 |
Host Hotels & Resorts LP, 5.70%, due 06/15/32 |
232,101 |
| 175,000 |
Host Hotels & Resorts LP, 5.50%, due 04/15/35 |
171,300 |
| 214,000 |
Howmet Aerospace, Inc., 3.00%, due 01/15/29 |
205,486 |
| 265,000 |
Humana, Inc., 5.50%, due 03/15/53 |
229,549 |
| 225,000 |
Humana, Inc., 5.75%, due 04/15/54 |
201,365 |
| 200,000 |
Illumina, Inc., 5.75%, due 12/13/27 |
202,288 |
| 356,000 |
Intel Corp., 3.10%, due 02/15/60 |
190,820 |
| 212,000 |
Intel Corp., 5.90%, due 02/10/63 |
189,684 |
| 119,000 |
Interstate Power & Light Co., 5.60%, due 06/29/35 |
119,604 |
| 200,000 |
JB Hunt Transport Services, Inc., 4.90%, due 03/15/30 |
199,016 |
| 185,000 |
Johnson Controls International PLC/Tyco Fire & Security Finance SCA, 5.50%, due 04/19/29 |
187,844 |
| 200,000 |
Johnson Controls International PLC/Tyco Fire & Security Finance SCA, 4.90%, due 12/01/32 |
196,902 |
| 20,000 |
KLA Corp., 4.70%, due 02/01/34 |
19,305 |
| 215,000 |
LYB International Finance III LLC, 5.63%, due 05/15/33 |
214,845 |
| 215,000 |
LYB International Finance III LLC, 5.88%, due 01/15/36 |
213,315 |
| 125,000 |
M&T Bank Corp., Variable Rate, 1 day USD SOFR + 1.61%, 5.39%, due 01/16/36 |
121,674 |
| 240,000 |
Marriott International, Inc., 5.50%, due 04/15/37 |
235,455 |
| 250,000 |
Marriott International, Inc., 5.10%, due 05/01/38 |
234,335 |
| 230,000 |
Marvell Technology, Inc., 5.75%, due 02/15/29 |
234,317 |
| Par Value† |
Description |
Value ($) |
| United States — continued | ||
| Corporate Debt — continued | ||
| 230,000 |
Marvell Technology, Inc., 5.95%, due 09/15/33 |
236,091 |
| 172,000 |
Morgan Stanley, Variable Rate, 1 day USD SOFR + 1.58%, 5.83%, due 04/19/35 |
174,773 |
| 181,000 |
Morgan Stanley, Variable Rate, 1 day USD SOFR + 1.56%, 5.32%, due 07/19/35 |
178,236 |
| 56,000 |
MPLX LP, 4.70%, due 04/15/48 |
45,166 |
| 56,000 |
MPLX LP, 5.50%, due 02/15/49 |
49,805 |
| 257,000 |
Mylan, Inc., 5.20%, due 04/15/48 |
207,635 |
| 230,000 |
NetApp, Inc., 5.50%, due 03/17/32 |
231,106 |
| 230,000 |
Nordson Corp., 5.80%, due 09/15/33 |
234,708 |
| 185,000 |
Occidental Petroleum Corp., 8.88%, due 07/15/30 |
206,074 |
| 210,000 |
Occidental Petroleum Corp., 6.20%, due 03/15/40 |
213,268 |
| 200,000 |
Ovintiv, Inc., 6.25%, due 07/15/33 |
209,018 |
| 205,000 |
Patterson-UTI Energy, Inc., 6.05%, due 05/15/36 |
203,609 |
| 230,000 |
Pinnacle Financial Partners, Inc., Variable Rate, 1 day USD SOFR + 2.35%, 6.17%, due 11/01/30 |
233,504 |
| 65,000 |
Pioneer Natural Resources Co., 1.90%, due 08/15/30 |
58,042 |
| 180,000 |
Royalty Pharma PLC, 5.40%, due 09/02/34 |
178,323 |
| 240,000 |
Royalty Pharma PLC, 5.20%, due 09/25/35 |
233,228 |
| 198,000 |
Santander Holdings USA, Inc., Variable Rate, 1 day USD SOFR + 2.14%, 6.34%, due 05/31/35 |
204,441 |
| 187,000 |
Simon Property Group LP, 5.85%, due 03/08/53 |
181,580 |
| 186,000 |
Simon Property Group LP, 6.65%, due 01/15/54 |
199,356 |
| 105,000 |
State Street Corp., Variable Rate, 1 day USD SOFR + 1.73%, 4.16%, due 08/04/33 |
99,365 |
| 200,000 |
Steel Dynamics, Inc., 5.38%, due 08/15/34 |
198,762 |
| 105,000 |
Steel Dynamics, Inc., 5.25%, due 05/15/35 |
103,121 |
| 202,000 |
Sun Communities Operating LP, 4.20%, due 04/15/32 |
190,052 |
| 239,000 |
System Energy Resources, Inc., 5.30%, due 12/15/34 |
233,416 |
| 56,000 |
Take-Two Interactive Software, Inc., 4.95%, due 03/28/28 |
56,146 |
| 210,000 |
Tapestry, Inc., 5.10%, due 03/11/30 |
209,833 |
| 215,000 |
Tapestry, Inc., 5.50%, due 03/11/35 |
211,387 |
| 205,000 |
Targa Resources Corp., 6.25%, due 07/01/52 |
201,496 |
| 200,000 |
Targa Resources Corp., 6.50%, due 02/15/53 |
202,585 |
| 265,000 |
Texas Instruments, Inc., 1.75%, due 05/04/30 |
237,361 |
| 235,000 |
Texas Instruments, Inc., 5.10%, due 05/23/35 |
230,867 |
| 245,000 |
UnitedHealth Group, Inc., 6.05%, due 02/15/63 |
237,292 |
| 250,000 |
UnitedHealth Group, Inc., 5.50%, due 04/15/64 |
221,906 |
See accompanying notes to the financial statements.
10
GMO Systematic Investment Grade Credit ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Par Value† / Shares |
Description |
Value ($) |
| United States — continued | ||
| Corporate Debt — continued | ||
| 251,000 |
Utah Acquisition Sub, Inc., 5.25%, due 06/15/46 |
206,316 |
| 220,000 |
Valero Energy Corp., 2.15%, due 09/15/27 |
214,865 |
| 65,000 |
Valero Energy Corp., 5.15%, due 03/10/36 |
62,837 |
| 201,000 |
Ventas Realty LP, 5.63%, due 07/01/34 |
202,383 |
| 75,000 |
Verizon Communications, Inc., 5.75%, due 11/30/45 |
70,009 |
| 220,000 |
Verizon Communications, Inc., 6.00%, due 11/30/65 |
202,307 |
| 247,000 |
Western Midstream Operating LP, 5.30%, due 03/01/48 |
210,318 |
| Total United States |
19,011,793 | |
| TOTAL DEBT OBLIGATIONS (COST $23,720,632) |
23,184,295 | |
| SHORT-TERM INVESTMENTS — 2.4% | ||
| Money Market Funds — 2.4% | ||
| 571,782 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (a) |
571,782 |
| TOTAL SHORT-TERM INVESTMENTS (COST $571,782) |
571,782 | |
| TOTAL INVESTMENTS — 100.5% (Cost $24,292,414) |
23,756,077 | |
| Other Assets and Liabilities (net) — (0.5)% |
(124,751 ) | |
| TOTAL NET ASSETS — 100.0% |
$23,631,326 | |
| Notes to Schedule of Investments: | |
| † |
Denominated in U.S. Dollar, unless otherwise indicated. |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
11
GMO U.S. Quality ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 99.6% | ||
| Banks — 1.8% | ||
| 1,550,481 |
U.S. Bancorp |
95,478,620 |
| Capital Goods — 1.8% | ||
| 275,790 |
General Electric Co. |
92,585,461 |
| Consumer Discretionary Distribution & Retail — 4.8% | ||
| 720,284 |
Amazon.com, Inc. * |
187,108,175 |
| 469,222 |
TJX Cos., Inc. |
62,833,518 |
| Total Consumer Discretionary Distribution & Retail |
249,941,693 | |
| Consumer Services — 4.0% | ||
| 2,103,981 |
Aramark |
118,475,170 |
| 278,886 |
Hilton Worldwide Holdings, Inc. |
88,206,064 |
| Total Consumer Services |
206,681,234 | |
| Financial Services — 7.1% | ||
| 142,058 |
Jack Henry & Associates, Inc. |
23,852,959 |
| 221,550 |
Mastercard, Inc. – Class A |
130,561,630 |
| 45,979 |
Moody's Corp. |
23,202,843 |
| 359,593 |
Tradeweb Markets, Inc. – Class A |
38,728,166 |
| 395,343 |
Visa, Inc. – Class A |
149,981,274 |
| Total Financial Services |
366,326,872 | |
| Food, Beverage & Tobacco — 5.1% | ||
| 1,543,254 |
Brown-Forman Corp. – Class B |
41,004,259 |
| 1,115,217 |
Coca-Cola Co. |
98,886,291 |
| 552,221 |
Constellation Brands, Inc. – Class A |
72,131,107 |
| 272,614 |
Philip Morris International, Inc. |
51,060,602 |
| Total Food, Beverage & Tobacco |
263,082,259 | |
| Health Care Equipment & Services — 11.1% | ||
| 1,204,146 |
Abbott Laboratories |
132,889,553 |
| 284,800 |
Cigna Group |
78,627,584 |
| 191,226 |
Elevance Health, Inc. |
75,063,854 |
| 145,745 |
Intuitive Surgical, Inc. * |
54,925,461 |
| 217,358 |
Quest Diagnostics, Inc. |
52,231,127 |
| 149,046 |
Stryker Corp. |
48,261,095 |
| 336,025 |
UnitedHealth Group, Inc. |
130,851,495 |
| Total Health Care Equipment & Services |
572,850,169 | |
| Household & Personal Products — 2.0% | ||
| 717,545 |
Procter & Gamble Co. |
104,130,130 |
| Media & Entertainment — 11.2% | ||
| 741,177 |
Alphabet, Inc. – Class A |
251,518,415 |
| 340,306 |
Meta Platforms, Inc. – Class A |
194,770,736 |
| 1,645,635 |
Netflix, Inc. * |
133,378,717 |
| Total Media & Entertainment |
579,667,868 | |
| Shares |
Description |
Value ($) |
| Pharmaceuticals, Biotechnology & Life Sciences — 12.7% | ||
| 113,248 |
Eli Lilly & Co. |
130,997,359 |
| 854,107 |
Johnson & Johnson |
227,064,346 |
| 565,623 |
Merck & Co., Inc. |
83,576,455 |
| 346,613 |
Thermo Fisher Scientific, Inc. |
213,894,882 |
| Total Pharmaceuticals, Biotechnology & Life Sciences |
655,533,042 | |
| Semiconductors & Semiconductor Equipment — 16.0% | ||
| 521,853 |
Broadcom, Inc. |
193,263,040 |
| 711,588 |
KLA Corp. |
124,848,114 |
| 659,479 |
Lam Research Corp. |
198,826,324 |
| 608,138 |
NVIDIA Corp. |
134,264,708 |
| 673,590 |
Texas Instruments, Inc. |
175,746,367 |
| Total Semiconductors & Semiconductor Equipment |
826,948,553 | |
| Software & Services — 16.2% | ||
| 611,065 |
Accenture PLC – Class A |
115,955,694 |
| 795,598 |
Microsoft Corp. |
403,598,909 |
| 230,193 |
PTC, Inc. * |
35,850,258 |
| 95,078 |
Roper Technologies, Inc. |
40,373,922 |
| 687,736 |
Salesforce, Inc. |
177,119,530 |
| 155,968 |
Synopsys, Inc. * |
68,561,973 |
| Total Software & Services |
841,460,286 | |
| Technology Hardware & Equipment — 4.5% | ||
| 742,971 |
Apple, Inc. |
235,410,361 |
| Transportation — 1.3% | ||
| 867,818 |
Uber Technologies, Inc. * |
65,650,432 |
| TOTAL COMMON STOCKS (COST $4,426,912,417) |
5,155,746,980 | |
| SHORT-TERM INVESTMENTS — 0.4% | ||
| Money Market Funds — 0.4% | ||
| 21,955,042 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (a) |
21,955,042 |
| TOTAL SHORT-TERM INVESTMENTS (COST $21,955,042) |
21,955,042 | |
| TOTAL INVESTMENTS — 100.0% (Cost $4,448,867,459) |
5,177,702,022 | |
| Other Assets and Liabilities (net) — 0.0% |
916,848 | |
| TOTAL NET ASSETS — 100.0% |
$5,178,618,870 | |
| Notes to Schedule of Investments: | |
| * |
Non-income producing security. |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
See accompanying notes to the financial statements.
12
GMO U.S. Quality ETF
Schedule of Investments — (Continued)
August 31, 2026 (Unaudited)
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
13
GMO U.S. Value ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| COMMON STOCKS — 99.1% | ||
| Automobiles & Components — 2.0% | ||
| 3,214 |
Autoliv, Inc. |
389,569 |
| 1,374 |
BorgWarner, Inc. |
88,156 |
| 47,300 |
Ford Motor Co. |
659,362 |
| 5,077 |
General Motors Co. |
438,246 |
| 4,215 |
Lear Corp. |
526,833 |
| Total Automobiles & Components |
2,102,166 | |
| Banks — 10.1% | ||
| 37,127 |
Bank of America Corp. |
2,299,646 |
| 8,754 |
Citigroup, Inc. |
1,152,201 |
| 1,670 |
Citizens Financial Group, Inc. |
115,013 |
| 1,948 |
Fifth Third Bancorp |
104,744 |
| 14,868 |
Huntington Bancshares, Inc. |
248,073 |
| 7,469 |
JPMorgan Chase & Co. |
2,659,113 |
| 2,410 |
M&T Bank Corp. |
563,795 |
| 3,880 |
PNC Financial Services Group, Inc. |
929,764 |
| 11,377 |
Truist Financial Corp. |
564,072 |
| 20,482 |
U.S. Bancorp |
1,261,282 |
| 10,099 |
Wells Fargo & Co. |
872,453 |
| Total Banks |
10,770,156 | |
| Capital Goods — 1.6% | ||
| 1,610 |
A.O. Smith Corp. |
95,200 |
| 1,975 |
AGCO Corp. |
233,662 |
| 5,767 |
Fortune Brands Innovations, Inc. |
255,651 |
| 1,670 |
Northrop Grumman Corp. |
901,299 |
| 1,682 |
Oshkosh Corp. |
259,213 |
| Total Capital Goods |
1,745,025 | |
| Commercial & Professional Services — 2.0% | ||
| 12,550 |
Booz Allen Hamilton Holding Corp. |
949,408 |
| 3,043 |
Genpact Ltd. |
115,573 |
| 1,407 |
Leidos Holdings, Inc. |
197,275 |
| 1,743 |
ManpowerGroup, Inc. |
109,722 |
| 2,678 |
Paycom Software, Inc. |
640,310 |
| 3,808 |
Robert Half, Inc. |
172,655 |
| Total Commercial & Professional Services |
2,184,943 | |
| Consumer Discretionary Distribution & Retail — 3.2% | ||
| 2,223 |
Abercrombie & Fitch Co. – Class A * |
318,067 |
| 5,820 |
Academy Sports & Outdoors, Inc. |
250,027 |
| 837 |
AutoNation, Inc. * |
168,446 |
| 8,013 |
Bath & Body Works, Inc. |
154,250 |
| 2,303 |
Best Buy Co., Inc. |
184,586 |
| 3,698 |
eBay, Inc. |
382,965 |
| 15,945 |
Gap, Inc. |
355,733 |
| 503 |
Group 1 Automotive, Inc. |
135,579 |
| 5,778 |
Kohl's Corp. |
102,964 |
| 8,471 |
LKQ Corp. |
212,622 |
| 1,134 |
Lowe's Cos., Inc. |
232,130 |
| Shares |
Description |
Value ($) |
| Consumer Discretionary Distribution & Retail — continued | ||
| 31,172 |
Macy's, Inc. |
684,537 |
| 2,926 |
Signet Jewelers Ltd. |
240,751 |
| Total Consumer Discretionary Distribution & Retail |
3,422,657 | |
| Consumer Durables & Apparel — 2.2% | ||
| 4,581 |
Dr. Horton, Inc. |
662,229 |
| 6,393 |
KB Home |
340,747 |
| 1,437 |
Lennar Corp. – Class A |
120,866 |
| 396 |
M/I Homes, Inc. * |
58,929 |
| 14,260 |
Mattel, Inc. * |
213,187 |
| 3,539 |
Meritage Homes Corp. |
245,713 |
| 3,580 |
NIKE, Inc. – Class B |
139,835 |
| 2,193 |
PulteGroup, Inc. |
277,020 |
| 2,058 |
PVH Corp. |
152,621 |
| 483 |
Toll Brothers, Inc. |
69,286 |
| 2,971 |
YETI Holdings, Inc. * |
121,960 |
| Total Consumer Durables & Apparel |
2,402,393 | |
| Consumer Services — 1.0% | ||
| 626 |
Covista, Inc. * |
82,839 |
| 15,516 |
H&R Block, Inc. |
801,401 |
| 4,251 |
Perdoceo Education Corp. |
141,303 |
| Total Consumer Services |
1,025,543 | |
| Consumer Staples Distribution & Retail — 2.2% | ||
| 15,957 |
Albertsons Cos., Inc. – Class A |
197,069 |
| 1,178 |
Dollar General Corp. |
149,311 |
| 8,728 |
Kroger Co. |
502,209 |
| 753 |
Sysco Corp. |
61,053 |
| 8,954 |
Target Corp. |
1,440,520 |
| Total Consumer Staples Distribution & Retail |
2,350,162 | |
| Energy — 9.0% | ||
| 12,187 |
APA Corp. |
525,869 |
| 4,730 |
Chevron Corp. |
975,042 |
| 7,853 |
ConocoPhillips |
1,040,444 |
| 17,780 |
Devon Energy Corp. |
862,508 |
| 9,361 |
EOG Resources, Inc. |
1,356,971 |
| 23,430 |
ExxonMobil Holdings Corp. |
3,771,059 |
| 5,517 |
Halliburton Co. |
203,301 |
| 4,442 |
Kinder Morgan, Inc. |
143,210 |
| 827 |
Marathon Petroleum Corp. |
308,736 |
| 2,252 |
Occidental Petroleum Corp. |
135,525 |
| 1,149 |
Phillips 66 |
283,320 |
| Total Energy |
9,605,985 | |
| Equity Real Estate Investment Trusts (REITs) — 0.6% | ||
| 24,290 |
VICI Properties, Inc. – (REIT) |
623,039 |
See accompanying notes to the financial statements.
14
GMO U.S. Value ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| Financial Services — 6.3% | ||
| 2,097 |
American Express Co. |
692,367 |
| 1,031 |
Ameriprise Financial, Inc. |
570,256 |
| 298 |
Berkshire Hathaway, Inc. – Class B * |
150,201 |
| 5,657 |
Blue Owl Capital Corp. |
65,225 |
| 1,491 |
Bread Financial Holdings, Inc. |
155,765 |
| 7,101 |
Capital One Financial Corp. |
1,523,236 |
| 694 |
Enova International, Inc. * |
157,344 |
| 1,400 |
Federated Hermes, Inc. |
89,110 |
| 1,437 |
Franklin Templeton, Inc. |
49,074 |
| 12,073 |
MGIC Investment Corp. |
370,037 |
| 15,462 |
PayPal Holdings, Inc. |
814,306 |
| 11,607 |
Radian Group, Inc. |
416,227 |
| 7,952 |
SLM Corp. |
206,513 |
| 3,803 |
State Street Corp. |
727,818 |
| 3,511 |
Synchrony Financial |
270,628 |
| 2,520 |
T. Rowe Price Group, Inc. |
280,426 |
| 32,646 |
Western Union Co. |
233,745 |
| Total Financial Services |
6,772,278 | |
| Food, Beverage & Tobacco — 2.6% | ||
| 5,994 |
Archer-Daniels-Midland Co. |
487,252 |
| 5,076 |
Brown-Forman Corp. – Class B |
134,869 |
| 9,027 |
General Mills, Inc. |
371,912 |
| 1,426 |
Ingredion, Inc. |
147,534 |
| 2,888 |
Keurig Dr. Pepper, Inc. |
92,012 |
| 6,013 |
Mondelez International, Inc. – Class A |
373,227 |
| 8,725 |
PepsiCo, Inc. |
1,224,467 |
| Total Food, Beverage & Tobacco |
2,831,273 | |
| Health Care Equipment & Services — 6.3% | ||
| 1,254 |
Becton Dickinson & Co. |
235,890 |
| 6,481 |
Cigna Group |
1,789,275 |
| 9,535 |
CVS Health Corp. |
895,432 |
| 3,313 |
Elevance Health, Inc. |
1,300,485 |
| 2,116 |
GE HealthCare Technologies, Inc. |
150,723 |
| 1,452 |
Humana, Inc. |
556,450 |
| 13,062 |
Medtronic PLC |
1,184,070 |
| 1,152 |
UnitedHealth Group, Inc. |
448,600 |
| 885 |
Universal Health Services, Inc. – Class B |
150,742 |
| Total Health Care Equipment & Services |
6,711,667 | |
| Household & Personal Products — 2.7% | ||
| 1,925 |
Colgate-Palmolive Co. |
172,904 |
| 23,793 |
Kenvue, Inc. |
449,212 |
| 4,675 |
Kimberly-Clark Corp. |
504,666 |
| 11,858 |
Procter & Gamble Co. |
1,720,833 |
| Total Household & Personal Products |
2,847,615 | |
| Insurance — 7.1% | ||
| 2,352 |
Aflac, Inc. |
272,479 |
| 5,440 |
Allstate Corp. |
1,402,432 |
| 7,631 |
American International Group, Inc. |
582,703 |
| 3,188 |
Arch Capital Group Ltd. * |
312,647 |
| Shares |
Description |
Value ($) |
| Insurance — continued | ||
| 2,630 |
Chubb Ltd. |
890,518 |
| 5,894 |
Hartford Insurance Group, Inc. |
809,718 |
| 1,810 |
Lincoln National Corp. |
77,088 |
| 5,372 |
MetLife, Inc. |
511,253 |
| 8,128 |
Progressive Corp. |
1,772,554 |
| 2,208 |
Prudential Financial, Inc. |
259,661 |
| 1,744 |
Travelers Cos., Inc. |
638,182 |
| 891 |
Unum Group |
83,059 |
| Total Insurance |
7,612,294 | |
| Materials — 1.4% | ||
| 1,204 |
CF Industries Holdings, Inc. |
156,556 |
| 2,074 |
Commercial Metals Co. |
139,933 |
| 4,095 |
CRH PLC |
386,117 |
| 3,575 |
Eastman Chemical Co. |
258,973 |
| 1,640 |
Nucor Corp. |
409,410 |
| 1,528 |
PPG Industries, Inc. |
171,396 |
| Total Materials |
1,522,385 | |
| Media & Entertainment — 6.6% | ||
| 2,180 |
Fox Corp. – Class B |
131,279 |
| 10,403 |
Match Group, Inc. |
422,882 |
| 10,008 |
Meta Platforms, Inc. – Class A |
5,727,979 |
| 6,869 |
Walt Disney Co. |
738,761 |
| Total Media & Entertainment |
7,020,901 | |
| Pharmaceuticals, Biotechnology & Life Sciences — 11.5% | ||
| 33,047 |
Bristol-Myers Squibb Co. |
2,207,870 |
| 679 |
Gilead Sciences, Inc. |
99,365 |
| 839 |
Incyte Corp. * |
103,382 |
| 8,091 |
Johnson & Johnson |
2,150,992 |
| 22,733 |
Merck & Co., Inc. |
3,359,028 |
| 90,575 |
Pfizer, Inc. |
2,577,765 |
| 2,256 |
Regeneron Pharmaceuticals, Inc. |
1,802,724 |
| Total Pharmaceuticals, Biotechnology & Life Sciences |
12,301,126 | |
| Real Estate Management & Development — 0.1% | ||
| 1,032 |
CBRE Group, Inc. – Class A * |
150,476 |
| Semiconductors & Semiconductor Equipment — 2.2% | ||
| 606 |
NXP Semiconductors NV |
136,132 |
| 12,415 |
QUALCOMM, Inc. |
2,116,509 |
| 2,243 |
Skyworks Solutions, Inc. |
150,303 |
| Total Semiconductors & Semiconductor Equipment |
2,402,944 | |
| Software & Services — 10.4% | ||
| 8,370 |
Cognizant Technology Solutions Corp. – Class A |
540,535 |
| 356 |
Gartner, Inc. * |
70,527 |
See accompanying notes to the financial statements.
15
GMO U.S. Value ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Shares |
Description |
Value ($) |
| Software & Services — continued | ||
| 3,079 |
Gen Digital, Inc. |
95,449 |
| 4,224 |
International Business Machines Corp. |
987,867 |
| 503 |
Intuit, Inc. |
180,728 |
| 15,556 |
Microsoft Corp. |
7,891,403 |
| 903 |
Roper Technologies, Inc. |
383,450 |
| 2,839 |
Salesforce, Inc. |
731,156 |
| 2,935 |
Zoom Communications, Inc. * |
283,756 |
| Total Software & Services |
11,164,871 | |
| Technology Hardware & Equipment — 1.6% | ||
| 4,846 |
Avnet, Inc. |
434,008 |
| 6,130 |
Hewlett Packard Enterprise Co. |
320,231 |
| 16,865 |
HP, Inc. |
506,287 |
| 923 |
NetApp, Inc. |
171,023 |
| 1,222 |
TE Connectivity PLC |
250,815 |
| Total Technology Hardware & Equipment |
1,682,364 | |
| Telecommunication Services — 4.6% | ||
| 45,397 |
AT&T, Inc. |
1,175,328 |
| 40,282 |
Comcast Corp. – Class A |
1,072,307 |
| 54,461 |
Verizon Communications, Inc. |
2,724,139 |
| Total Telecommunication Services |
4,971,774 | |
| Transportation — 1.7% | ||
| 3,122 |
Delta Air Lines, Inc. |
243,516 |
| 1,244 |
FedEx Corp. |
407,286 |
| 11,050 |
United Parcel Service, Inc. – Class B |
1,151,741 |
| Total Transportation |
1,802,543 | |
| Utilities — 0.1% | ||
| 1,331 |
Edison International |
71,847 |
| TOTAL COMMON STOCKS (COST $97,222,382) |
106,098,427 | |
| SHORT-TERM INVESTMENTS — 0.7% | ||
| Money Market Funds — 0.7% | ||
| 793,480 |
State Street Institutional Treasury Money Market Fund – Premier Class, 3.64% (a) |
793,480 |
| TOTAL SHORT-TERM INVESTMENTS (COST $793,480) |
793,480 | |
| TOTAL INVESTMENTS — 99.8% (Cost $98,015,862) |
106,891,907 | |
| Other Assets and Liabilities (net) — 0.2% |
161,022 | |
| TOTAL NET ASSETS — 100.0% |
$107,052,929 | |
| Notes to Schedule of Investments: | |
| * |
Non-income producing security. |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
16
GMO Ultra-Short Income ETF
Schedule of Investments
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Par Value† |
Description |
Value ($) |
| DEBT OBLIGATIONS — 96.6% | ||
| Asset-Backed Securities — 70.4% | ||
| Collateralized Loan Obligations — 70.4% | ||
| 150,000 |
37 Capital CLO 3 Ltd., Series 2023-1A, XR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.00%, 4.75%, due 07/15/38 |
149,972 |
| 34,683 |
Apex Credit CLO Ltd., Series 2018-1A, AR, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.98%, 4.79%, due 04/25/31 |
34,681 |
| 165,758 |
Bain Capital Credit CLO Ltd., Series 2019-2A, AR3, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.92%, 4.67%, due 10/17/32 |
165,758 |
| 1,357,895 |
Bain Capital Credit CLO Ltd., Series 2023-2A, XR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.10%, 4.83%, due 07/18/38 |
1,360,249 |
| 1,031,314 |
Battalion CLO X Ltd., Series 2016-10A, A1R3, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.14%, 4.92%, due 01/24/35 |
1,031,615 |
| 786,431 |
Battalion CLO XV Ltd., Series 2020-15A, A1RR, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.98%, 4.73%, due 01/17/33 |
786,411 |
| 3,449 |
BlueMountain CLO XXII Ltd., Series 2018-22A, A1, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.34%, 5.10%, due 07/15/31 |
3,450 |
| 34,265 |
California Street CLO IX LP, Series 2012-9A, AR3, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.36%, 5.16%, due 07/16/32 |
34,302 |
| 170,990 |
CarVal CLO III Ltd., Series 2019-2A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.99%, 4.72%, due 07/20/32 |
171,031 |
| 74,415 |
Dryden 40 Senior Loan Fund, Series 2015-40A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.15%, 4.89%, due 08/15/31 |
74,519 |
| 21,453 |
Dryden 55 CLO Ltd., Series 2018-55A, A1, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.28%, 5.04%, due 04/15/31 |
21,465 |
| 204,567 |
Dryden 72 CLO Ltd., Series 2019-72A, ARR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.10%, 4.84%, due 05/15/32 |
204,632 |
| 393,125 |
Elmwood CLO X Ltd., Series 2021-3A, X, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.95%, 4.68%, due 07/20/38 |
393,110 |
| 565,930 |
Fortress Credit BSL X Ltd., Series 2021-1A, AR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.10%, 4.83%, due 04/20/33 |
566,034 |
| 97,242 |
Greywolf CLO III Ltd., Series 2020-3RA, A1R2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.23%, 4.97%, due 04/22/33 |
97,311 |
| 1,274,984 |
Greywolf CLO IV Ltd., Series 2019-1A, A1R2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.24%, 4.99%, due 04/17/34 |
1,275,637 |
| 114,239 |
ICG U.S. CLO Ltd., Series 2015-2RA, A1R, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.99%, 4.78%, due 01/16/33 |
114,210 |
| 1,650,000 |
KKR Financial CLO Ltd., Series 2013-1A, XR, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.85%, 4.60%, due 10/15/38 |
1,647,537 |
| Par Value† |
Description |
Value ($) |
| Asset-Backed Securities — continued | ||
| Collateralized Loan Obligations — continued | ||
| 150,000 |
LCM 31 Ltd., Series 31A, AR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.28%, 5.01%, due 07/20/34 |
150,055 |
| 784,698 |
LCM 37 Ltd., Series 37A, A1R, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.06%, 4.81%, due 04/15/34 |
784,322 |
| 63,213 |
Madison Park Funding XIV Ltd., Series 2014-14A, AR4, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.96%, 4.69%, due 10/22/30 |
63,204 |
| 554,167 |
Magnetite XXVI Ltd., Series 2020-26A, XR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.90%, 4.71%, due 01/25/38 |
555,048 |
| 641,977 |
Mountain View CLO LLC, Series 2016-1A, AR3, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.88%, 4.62%, due 04/14/33 |
641,817 |
| 261,763 |
Northwoods Capital XIV-B Ltd., Series 2018-14BA, AR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.25%, 5.00%, due 11/13/31 |
261,717 |
| 87,684 |
OZLM XV Ltd., Series 2016-15A, A1R3, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.05%, 4.78%, due 04/20/33 |
87,642 |
| 1,500,000 |
Palmer Square CLO Ltd., Series 2021-4A, XR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.00%, 4.75%, due 07/15/38 |
1,502,533 |
| 173,143 |
Regatta XX Funding Ltd., Series 2021-2A, X, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.97%, 4.72%, due 01/15/38 |
173,139 |
| 260,745 |
Rockford Tower CLO Ltd., Series 2019-2A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.13%, 4.86%, due 08/20/32 |
260,868 |
| 96,747 |
Sound Point CLO II Ltd., Series 2013-1A, A2R, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.71%, 5.52%, due 01/26/31 |
96,799 |
| 262,968 |
Sound Point CLO IX Ltd., Series 2015-2A, ARRR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.47%, 5.20%, due 07/20/32 |
263,144 |
| 114,091 |
Sound Point CLO V-R Ltd., Series 2014-1RA, A, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.41%, 5.14%, due 07/18/31 |
114,215 |
| 605,689 |
Sound Point CLO XXII Ltd., Series 2019-1A, ARR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.03%, 4.76%, due 01/20/32 |
605,658 |
| 28,177 |
Symphony CLO XX Ltd., Series 2018-20A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.10%, 4.89%, due 01/16/32 |
28,221 |
| 1,428,954 |
Symphony CLO XXIII Ltd., Series 2020-23A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.90%, 4.65%, due 01/15/34 |
1,429,307 |
| 446,343 |
THL Credit Wind River CLO Ltd., Series 2017-3A, AR2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.20%, 4.95%, due 04/15/35 |
446,439 |
| 284,514 |
Trinitas CLO XII Ltd., Series 2020-12A, A1R2, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.05%, 4.86%, due 04/25/33 |
284,713 |
See accompanying notes to the financial statements.
17
GMO Ultra-Short Income ETF
Schedule of Investments — (Continued)
(showing percentage of total net assets)
August 31, 2026 (Unaudited)
| Par Value† / Shares |
Description |
Value ($) |
| Asset-Backed Securities — continued | ||
| Collateralized Loan Obligations — continued | ||
| 6,737 |
Venture 32 CLO Ltd., Series 2018-32A, A1, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.36%, 5.09%, due 07/18/31 |
6,742 |
| 1,087,245 |
Venture 38 CLO Ltd., Series 2019-38A, ARR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.00%, 4.84%, due 07/30/32 |
1,087,999 |
| 245,311 |
Venture XIX CLO Ltd., Series 2014-19A, ARR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.52%, 5.28%, due 01/15/32 |
245,842 |
| 796,409 |
Venture XV CLO Ltd., Series 2013-15A, AR3, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.44%, 5.20%, due 07/15/32 |
796,968 |
| 631,154 |
Voya CLO Ltd., Series 2019-3A, AR, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.34%, 5.09%, due 10/17/32 |
631,784 |
| 166,667 |
Voya CLO Ltd., Series 2025-1A, X, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.90%, 4.63%, due 04/20/38 |
166,719 |
| 2,469,041 |
Wellfleet CLO Ltd., Series 2020-1A, A1RR, 144A, Variable Rate, 3 mo. USD Term SOFR + 0.99%, 4.74%, due 04/15/33 |
2,469,434 |
| 1,600,000 |
Wellfleet CLO Ltd., Series 2021-2A, A1R, 144A, Variable Rate, 3 mo. USD Term SOFR + 1.15%, 4.90%, due 07/15/34 |
1,600,848 |
| Total Collateralized Loan Obligations |
22,887,101 | |
| U.S. Government — 26.2% | ||
| 148,000 |
Federal Home Loan Bank Discount Notes, 0.00, due 10/09/26 |
147,405 |
| 436,000 |
U.S. Treasury Floating Rate Notes, Variable Rate, 3 mo. Treasury money market yield + 0.19%, 4.00%, due 10/31/27 |
436,832 |
| 638,000 |
U.S. Treasury Floating Rate Notes, Variable Rate, 3 mo. Treasury money market yield + 0.10%, 3.91%, due 04/30/28 |
638,479 |
| 850,000 |
U.S. Treasury Floating Rate Notes, Variable Rate, 3 mo. Treasury money market yield + 0.05%, 3.86%, due 07/31/28 |
849,952 |
| 18,334 |
U.S. Treasury Inflation-Indexed Notes, 0.13%, due 10/15/26 |
18,276 |
| 17,974 |
U.S. Treasury Inflation-Indexed Notes, 0.38%, due 01/15/27 |
17,820 |
| 330,415 |
U.S. Treasury Inflation-Indexed Notes, 0.38%, due 07/15/27 |
325,713 |
| 450,000 |
U.S. Treasury Notes, 1.87%, due 02/28/27 |
445,361 |
| 929,000 |
U.S. Treasury Notes, 3.62%, due 08/31/27 |
923,731 |
| 1,018,000 |
U.S. Treasury Notes, 3.50%, due 09/30/27 |
1,010,118 |
| 1,130,000 |
U.S. Treasury Notes, 3.37%, due 11/30/27 |
1,117,553 |
| 1,305,000 |
U.S. Treasury Notes, 3.87%, due 12/31/27 |
1,297,863 |
| 1,319,000 |
U.S. Treasury Notes, 3.50%, due 01/31/28 |
1,304,522 |
| Total U.S. Government |
8,533,625 | |
| TOTAL DEBT OBLIGATIONS (COST $31,462,624) |
31,420,726 | |
| SHORT-TERM INVESTMENTS — 3.2% | ||
| Money Market Funds — 0.2% | ||
| 74,711 |
State Street Institutional Treasury Plus Money Market Fund – Premier Class, 3.64% (a) |
74,711 |
| Shares |
Description |
Value ($) |
| Repurchase Agreements — 3.0% | ||
| 977,550 |
Daiwa Capital Markets America, Inc. Repurchase Agreement, dated 08/12/2026 to be returned on demand at face value plus an effective yield of 3.60%, collateralized by a U.S. Treasury Note, 4.00%, due 05/31/30 and a market value of $994,109. (b) |
977,550 |
| TOTAL SHORT-TERM INVESTMENTS (COST $1,052,261) |
1,052,261 | |
| TOTAL INVESTMENTS— 99.8% (Cost $32,514,885) |
32,472,987 | |
| Other Assets and Liabilities (net) — 0.2% |
55,991 | |
| TOTAL NET ASSETS — 100.0% |
$32,528,978 | |
| Notes to Schedule of Investments: | |
| † |
Denominated in U.S. Dollar, unless otherwise indicated. |
| (a) |
The rate disclosed is the 7 day net yield as of August 31, 2026. |
| (b) |
The repurchase agreement has an open maturity date and can be closed by either party on demand. |
For a listing of definitions of acronyms, counterparty abbreviations and currency abbreviations used throughout the Schedule of Investments as well as the derivative tables, if any, please refer to page 19.
See accompanying notes to the financial statements.
18
GMO ETF Trust
August 31, 2026 (Unaudited)
| Portfolio and Currency Abbreviations: |
| 144A – Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors. |
| ADR – American Depositary Receipt |
| CLO – Collateralized Loan Obligation |
| ETF – Exchange-Traded Fund |
| REIT – Real Estate Investment Trust |
| SOFR – Secured Overnight Financing Rate |
| USD – United States Dollar |
The rates shown on variable rate notes are the current interest rates at August 31, 2026, which are subject to change based on the terms of the security.
See accompanying notes to the financial statements.
19
GMO ETF Trust
Statements of Assets and Liabilities — August 31, 2026 (Unaudited)
| Domestic Resilience ETF |
Dynamic Allocation ETF |
International Quality ETF | |
| Assets: |
|||
| Investments in affiliated issuers, at value (Notes 2 and 8)(a) |
$— |
$18,385,481 |
$— |
| Investments in unaffiliated issuers, at value (Note 2)(b) |
36,380,510 |
27,013,065 |
297,090,967 |
| Foreign currency, at value (Note 2)(c) |
— |
— |
11,411 |
| Cash |
2,185 |
— |
— |
| Receivable for investments sold |
— |
— |
5,976,021 |
| Dividends and interest receivable |
59,292 |
849 |
177,529 |
| Dividend withholding tax receivable |
— |
— |
8,739 |
| Receivable for expenses reimbursed and/or waived by GMO (Note 3) |
— |
10,107 |
— |
| Total assets |
36,441,987 |
45,409,502 |
303,264,667 |
| Liabilities: |
|||
| Payable for investments purchased |
— |
— |
6,037,565 |
| Accrued advisory fee (Note 3) |
15,839 |
18,907 |
151,439 |
| Total liabilities |
15,839 |
18,907 |
6,189,004 |
| Net assets |
$36,426,148 |
$45,390,595 |
$297,075,663 |
| Net assets consist of: |
|||
| Paid in capital |
$34,058,058 |
$42,831,841 |
$279,266,133 |
| Distributable earnings (accumulated loss) |
2,368,090 |
2,558,754 |
17,809,530 |
| $36,426,148 |
$45,390,595 |
$297,075,663 | |
| Net asset value, offering and redemption price per share |
$30.36 |
$28.02 |
$27.76 |
| Shares outstanding (unlimited authorized - no par value) |
1,200,000 |
1,620,000 |
10,700,000 |
| (a) Cost of investments – affiliated issuers: |
$— |
$16,441,455 |
$— |
| (b) Cost of investments – unaffiliated issuers: |
$34,029,323 |
$26,512,127 |
$277,649,509 |
| (c) Cost of foreign currency: |
$— |
$— |
$11,357 |
See accompanying notes to the financial statements.
20
GMO ETF Trust
Statements of Assets and Liabilities — August 31, 2026 (Unaudited) — (Continued)
| International Value ETF |
Power Infrastructure ETF |
Systematic Investment Grade Credit ETF | |
| Assets: |
|||
| Investments in unaffiliated issuers, at value (Note 2)(a) |
$689,693,456 |
$57,465,567 |
$23,756,077 |
| Foreign currency, at value (Note 2)(b) |
242,147 |
— |
— |
| Cash |
90,754 |
— |
— |
| Receivable for investments sold |
214 |
— |
1,887,811 |
| Dividends and interest receivable |
1,500,201 |
96,511 |
356,668 |
| Dividend withholding tax receivable |
80,704 |
3,340 |
— |
| Total assets |
691,607,476 |
57,565,418 |
26,000,556 |
| Liabilities: |
|||
| Payable for investments purchased |
— |
— |
2,269,190 |
| Accrued advisory fee (Note 3) |
320,042 |
29,352 |
5,040 |
| Distributions payable (Note 2) |
— |
— |
95,000 |
| Total liabilities |
320,042 |
29,352 |
2,369,230 |
| Net assets |
$691,287,434 |
$57,536,066 |
$23,631,326 |
| Net assets consist of: |
|||
| Paid in capital |
$617,022,724 |
$57,244,661 |
$24,421,523 |
| Distributable earnings (accumulated loss) |
74,264,710 |
291,405 |
(790,197 ) |
| $691,287,434 |
$57,536,066 |
$23,631,326 | |
| Net asset value, offering and redemption price per share |
$41.27 |
$24.80 |
$24.88 |
| Shares outstanding (unlimited authorized - no par value) |
16,750,000 |
2,320,000 |
950,000 |
| (a) Cost of investments – unaffiliated issuers: |
$619,915,140 |
$57,321,444 |
$24,292,414 |
| (b) Cost of foreign currency: |
$242,217 |
$— |
$— |
See accompanying notes to the financial statements.
21
GMO ETF Trust
Statements of Assets and Liabilities — August 31, 2026 (Unaudited) — (Continued)
| U.S. Quality ETF |
U.S. Value ETF |
Ultra-Short Income ETF | |
| Assets: |
|||
| Investments in unaffiliated issuers, at value (Note 2)(a) |
$5,177,702,022 |
$106,891,907 |
$32,472,987 |
| Receivable for Fund shares sold |
1,721,272 |
— |
— |
| Dividends and interest receivable |
3,067,712 |
205,852 |
181,582 |
| Total assets |
5,182,491,006 |
107,097,759 |
32,654,569 |
| Liabilities: |
|||
| Payable for investments purchased |
1,713,078 |
— |
— |
| Accrued advisory fee (Note 3) |
2,159,058 |
44,830 |
5,536 |
| Distributions payable (Note 2) |
— |
— |
120,055 |
| Total liabilities |
3,872,136 |
44,830 |
125,591 |
| Net assets |
$5,178,618,870 |
$107,052,929 |
$32,528,978 |
| Net assets consist of: |
|||
| Paid in capital |
$4,503,694,766 |
$99,263,336 |
$32,569,622 |
| Distributable earnings (accumulated loss) |
674,924,104 |
7,789,593 |
(40,644 ) |
| $5,178,618,870 |
$107,052,929 |
$32,528,978 | |
| Net asset value, offering and redemption price per share |
$43.03 |
$32.64 |
$50.04 |
| Shares outstanding (unlimited authorized - no par value) |
120,344,000 |
3,280,000 |
650,000 |
| (a) Cost of investments – unaffiliated issuers: |
$4,448,867,459 |
$98,015,862 |
$32,514,885 |
See accompanying notes to the financial statements.
22
GMO ETF Trust
Statements of Operations —Six Months Ended August 31, 2026 (Unaudited)
| Domestic Resilience ETF |
Dynamic Allocation ETF |
International Quality ETF | |
| Investment income: |
|||
| Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a) |
$222,216 |
$407,556 |
$3,650,906 |
| Dividends from affiliated issuers (Note 8) |
— |
73,089 |
— |
| Other income |
— |
— |
31 |
| Total investment income |
222,216 |
480,645 |
3,650,937 |
| Expenses: |
|||
| Advisory fee (Note 3) |
92,630 |
97,360 |
858,539 |
| Total expenses |
92,630 |
97,360 |
858,539 |
| Indirectly incurred management fees waived or borne by GMO (Note 3) |
— |
(51,394 ) |
— |
| Net expenses |
92,630 |
45,966 |
858,539 |
| Net investment income (loss) |
129,586 |
434,679 |
2,792,398 |
| Realized and unrealized gain (loss): |
|||
| Net realized gain (loss) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
(10,096 ) |
(333,940 ) |
(4,020,181 ) |
| Investments in affiliated issuers |
— |
211,602 |
— |
| In-kind redemptions |
3,695,677 |
390,456 |
592,488 |
| Foreign currency and foreign currency related transactions |
— |
— |
(8,601 ) |
| Net realized gain (loss) |
3,685,581 |
268,118 |
(3,436,294 ) |
| Change in net unrealized appreciation (depreciation) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
(2,823,254 ) |
(437,532 ) |
(1,787,318 ) |
| Investments in affiliated issuers |
— |
1,067,197 |
— |
| Foreign currency and foreign currency related transactions |
— |
— |
(1,569 ) |
| Net change in unrealized appreciation (depreciation) |
(2,823,254 ) |
629,665 |
(1,788,887 ) |
| Net realized and unrealized gain (loss) |
862,327 |
897,783 |
(5,225,181 ) |
| Net increase (decrease) in net assets resulting from operations |
$991,913 |
$1,332,462 |
$(2,432,783 ) |
| (a)Withholding tax: |
$975 |
$— |
$757,143 |
See accompanying notes to the financial statements.
23
GMO ETF Trust
Statements of Operations —Six Months Ended August 31, 2026 (Unaudited) — (Continued)
| International Value ETF |
Power Infrastructure ETF* |
Systematic Investment Grade Credit ETF | |
| Investment income: |
|||
| Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a) |
$11,060,739 |
$156,976 |
$4,324 |
| Interest |
— |
— |
666,368 |
| Other income |
844 |
— |
1,463 |
| Total investment income |
11,061,583 |
156,976 |
672,155 |
| Expenses: |
|||
| Advisory fee (Note 3) |
1,450,974 |
40,116 |
32,949 |
| Total expenses |
1,450,974 |
40,116 |
32,949 |
| Net investment income (loss) |
9,610,609 |
116,860 |
639,206 |
| Realized and unrealized gain (loss): |
|||
| Net realized gain (loss) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
(1,962,419 ) |
36,074 |
(279,089 ) |
| In-kind redemptions |
38,686,397 |
— |
(54,110 ) |
| Foreign currency and foreign currency related transactions |
(75,816 ) |
(5,700 ) |
— |
| Net realized gain (loss) |
36,648,162 |
30,374 |
(333,199 ) |
| Change in net unrealized appreciation (depreciation) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
(68,221 ) |
144,123 |
(666,963 ) |
| Foreign currency and foreign currency related transactions |
3,603 |
48 |
— |
| Net change in unrealized appreciation (depreciation) |
(64,618 ) |
144,171 |
(666,963 ) |
| Net realized and unrealized gain (loss) |
36,583,544 |
174,545 |
(1,000,162 ) |
| Net increase (decrease) in net assets resulting from operations |
$46,194,153 |
$291,405 |
$(360,956 ) |
| (a)Withholding tax: |
$1,653,658 |
$5,709 |
$— |
| * |
Period from July 14, 2026 (commencement of operations) through August 31, 2026. |
See accompanying notes to the financial statements.
24
GMO ETF Trust
Statements of Operations —Six Months Ended August 31, 2026 (Unaudited) — (Continued)
| U.S. Quality ETF |
U.S. Value ETF |
Ultra-Short Income ETF | |
| Investment income: |
|||
| Dividends from unaffiliated issuers (Net of withholding tax) (Note 2)(a) |
$25,361,551 |
$1,117,898 |
$7,281 |
| Interest |
— |
— |
633,685 |
| Other income |
— |
— |
23,788 |
| Total investment income |
25,361,551 |
1,117,898 |
664,754 |
| Expenses: |
|||
| Advisory fee (Note 3) |
10,985,705 |
228,165 |
28,733 |
| Total expenses |
10,985,705 |
228,165 |
28,733 |
| Net investment income (loss) |
14,375,846 |
889,733 |
636,021 |
| Realized and unrealized gain (loss): |
|||
| Net realized gain (loss) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
(39,979,971 ) |
50,146 |
(23,386 ) |
| In-kind redemptions |
108,991,510 |
7,487,590 |
— |
| Net realized gain (loss) |
69,011,539 |
7,537,736 |
(23,386 ) |
| Change in net unrealized appreciation (depreciation) on: |
|||
| Investments in unaffiliated issuers (Note 2) |
418,204,654 |
2,871,409 |
(43,406 ) |
| Net realized and unrealized gain (loss) |
487,216,193 |
10,409,145 |
(66,792 ) |
| Net increase (decrease) in net assets resulting from operations |
$501,592,039 |
$11,298,878 |
$569,229 |
| (a)Withholding tax: |
$— |
$299 |
$— |
See accompanying notes to the financial statements.
25
GMO ETF Trust
Statements of Changes in Net Assets
| Domestic Resilience ETF |
Dynamic Allocation ETF | |||
| Six Month Ended August 31, 2026 (Unaudited) |
Period from September 30, 2025 (commencement of operations) through February 28, 2026 |
Six Month Ended August 31, 2026 (Unaudited) |
Period from October 13, 2025 (commencement of operations) through February 28, 2026 | |
| Increase (decrease) in net assets: |
||||
| Operations: |
||||
| Net investment income (loss) |
$129,586 |
$89,705 |
$434,679 |
$186,367 |
| Net realized gain (loss) |
3,685,581 |
239,947 |
268,118 |
(13,389 ) |
| Change in net unrealized appreciation (depreciation) |
(2,823,254 ) |
5,174,441 |
629,665 |
1,815,299 |
| Net increase (decrease) in net assets from operations |
991,913 |
5,504,093 |
1,332,462 |
1,988,277 |
| Distributions to shareholders |
(127,089 ) |
(65,090 ) |
(200,067 ) |
(172,008 ) |
| Capital share transactions: |
||||
| Subscriptions |
10,658,769 |
35,153,181 |
14,450,923 |
33,380,320 |
| Redemptions |
(14,403,169 ) |
(1,286,460 ) |
(5,389,312 ) |
— |
| Increase (decrease) in net assets from capital transactions |
(3,744,400 ) |
33,866,721 |
9,061,611 |
33,380,320 |
| Total increase (decrease) in net assets |
(2,879,576 ) |
39,305,724 |
10,194,006 |
35,196,589 |
| Net assets: |
||||
| Beginning of period |
39,305,724 |
— |
35,196,589 |
— |
| End of period |
$36,426,148 |
$39,305,724 |
$45,390,595 |
$35,196,589 |
See accompanying notes to the financial statements.
26
GMO ETF Trust
Statements of Changes in Net Assets — (Continued)
| International Quality ETF |
International Value ETF | |||
| Six Month Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Six Month Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 | |
| Increase (decrease) in net assets: |
||||
| Operations: |
||||
| Net investment income (loss) |
$2,792,398 |
$388,776 |
$9,610,609 |
$2,446,914 |
| Net realized gain (loss) |
(3,436,294 ) |
1,920,391 |
36,648,162 |
16,741,385 |
| Change in net unrealized appreciation (depreciation) |
(1,788,887 ) |
18,736,443 |
(64,618 ) |
56,942,247 |
| Net increase (decrease) in net assets from operations |
(2,432,783 ) |
21,045,610 |
46,194,153 |
76,130,546 |
| Distributions to shareholders |
(266,600 ) |
(629,950 ) |
(1,844,640 ) |
(5,768,340 ) |
| Capital share transactions: |
||||
| Subscriptions |
14,970,155 |
215,884,485 |
333,318,130 |
281,564,840 |
| Redemptions |
(2,662,870 ) |
(5,278,850 ) |
(135,145,515 ) |
(66,215,610 ) |
| Increase (decrease) in net assets from capital transactions |
12,307,285 |
210,605,635 |
198,172,615 |
215,349,230 |
| Total increase (decrease) in net assets |
9,607,902 |
231,021,295 |
242,522,128 |
285,711,436 |
| Net assets: |
||||
| Beginning of period |
287,467,761 |
56,446,466 |
448,765,306 |
163,053,870 |
| End of period |
$297,075,663 |
$287,467,761 |
$691,287,434 |
$448,765,306 |
See accompanying notes to the financial statements.
27
GMO ETF Trust
Statements of Changes in Net Assets — (Continued)
| Power Infrastructure ETF |
Systematic Investment Grade Credit ETF | ||
| Period from July 14, 2026 (commencement of operations) through August 31, 2026 (Unaudited) |
Six Month Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 | |
| Increase (decrease) in net assets: |
|||
| Operations: |
|||
| Net investment income (loss) |
$116,860 |
$639,206 |
$471,092 |
| Net realized gain (loss) |
30,374 |
(333,199 ) |
124,118 |
| Change in net unrealized appreciation (depreciation) |
144,171 |
(666,963 ) |
23,348 |
| Net increase (decrease) in net assets from operations |
291,405 |
(360,956 ) |
618,558 |
| Distributions to shareholders |
— |
(717,155 ) |
(442,160 ) |
| Capital share transactions: |
|||
| Subscriptions |
57,244,661 |
3,795,425 |
21,985,375 |
| Redemptions |
— |
(3,759,240 ) |
(3,869,325 ) |
| Increase (decrease) in net assets from capital transactions |
57,244,661 |
36,185 |
18,116,050 |
| Total increase (decrease) in net assets |
57,536,066 |
(1,041,926 ) |
18,292,448 |
| Net assets: |
|||
| Beginning of period |
— |
24,673,252 |
6,380,804 |
| End of period |
$57,536,066 |
$23,631,326 |
$24,673,252 |
See accompanying notes to the financial statements.
28
GMO ETF Trust
Statements of Changes in Net Assets — (Continued)
| U.S. Quality ETF |
U.S. Value ETF | |||
| Six Month Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Six Month Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 | |
| Increase (decrease) in net assets: |
||||
| Operations: |
||||
| Net investment income (loss) |
$14,375,846 |
$14,331,370 |
$889,733 |
$939,619 |
| Net realized gain (loss) |
69,011,539 |
183,590,076 |
7,537,736 |
3,448,909 |
| Change in net unrealized appreciation (depreciation) |
418,204,654 |
136,909,614 |
2,871,409 |
5,694,227 |
| Net increase (decrease) in net assets from operations |
501,592,039 |
334,831,060 |
11,298,878 |
10,082,755 |
| Distributions to shareholders |
(14,509,982 ) |
(16,215,144 ) |
(863,232 ) |
(960,252 ) |
| Capital share transactions: |
||||
| Subscriptions |
1,542,922,090 |
1,557,147,863 |
45,836,028 |
44,003,868 |
| Redemptions |
(315,059,602 ) |
(422,363,759 ) |
(29,953,224 ) |
(24,938,956 ) |
| Increase (decrease) in net assets from capital transactions |
1,227,862,488 |
1,134,784,104 |
15,882,804 |
19,064,912 |
| Total increase (decrease) in net assets |
1,714,944,545 |
1,453,400,020 |
26,318,450 |
28,187,415 |
| Net assets: |
||||
| Beginning of period |
3,463,674,325 |
2,010,274,305 |
80,734,479 |
52,547,064 |
| End of period |
$5,178,618,870 |
$3,463,674,325 |
$107,052,929 |
$80,734,479 |
See accompanying notes to the financial statements.
29
GMO ETF Trust
Statements of Changes in Net Assets — (Continued)
| Ultra-Short Income ETF | ||
| Six Month Ended August 31, 2026 (Unaudited) |
Period from October 27, 2025 (commencement of operations) through February 28, 2026 | |
| Increase (decrease) in net assets: |
||
| Operations: |
||
| Net investment income (loss) |
$636,021 |
$124,694 |
| Net realized gain (loss) |
(23,386 ) |
(2,248 ) |
| Change in net unrealized appreciation (depreciation) |
(43,406 ) |
1,508 |
| Net increase (decrease) in net assets from operations |
569,229 |
123,954 |
| Distributions to shareholders |
(653,197 ) |
(78,280 ) |
| Capital share transactions: |
||
| Subscriptions |
28,812,881 |
13,136,066 |
| Redemptions |
(9,381,675 ) |
— |
| Increase (decrease) in net assets from capital transactions |
19,431,206 |
13,136,066 |
| Total increase (decrease) in net assets |
19,347,238 |
13,181,740 |
| Net assets: |
||
| Beginning of period |
13,181,740 |
— |
| End of period |
$32,528,978 |
$13,181,740 |
See accompanying notes to the financial statements.
30
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
Domestic Resilience ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from September 30, 2025 (commencement of operations) through February 28, 2026 | |
| Net asset value, beginning of period |
$29.78 |
$25.00 |
| Income (loss) from investment operations: |
||
| Net investment income (loss)† |
0.11 |
0.09 |
| Net realized & unrealized gain (loss) |
0.57 |
4.75 |
| Total from investment operations |
0.68 |
4.84 |
| Less distributions to shareholders: |
||
| From net investment income |
(0.10 ) |
(0.06 ) |
| Total distributions |
(0.10 ) |
(0.06 ) |
| Net asset value, end of period |
$30.36 |
$29.78 |
| Total return on net asset value(a) ** |
2.30 % |
19.37 % |
| Ratios/Supplemental Data: |
||
| Net assets, end of period (000's) |
$36,426 |
$39,306 |
| Net operating expenses to average daily net assets* |
0.50 % |
0.50 % |
| Net investment income (loss) to average daily net assets* |
0.70 % |
0.79 % |
| Portfolio turnover rate(b) ** |
1 % |
0 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
31
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
Dynamic Allocation ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from October 13, 2025 (commencement of operations) through February 28, 2026 | |
| Net asset value, beginning of period |
$27.28 |
$24.84 |
| Income (loss) from investment operations: |
||
| Net investment income (loss)† |
0.31 |
0.28 |
| Net realized & unrealized gain (loss) |
0.57 |
2.40 |
| Total from investment operations |
0.88 |
2.68 |
| Less distributions to shareholders: |
||
| From net investment income |
(0.14 ) |
(0.24 ) |
| Total distributions |
(0.14 ) |
(0.24 ) |
| Net asset value, end of period |
$28.02 |
$27.28 |
| Total return on net asset value(a) ** |
3.20 % |
10.85 % |
| Ratios/Supplemental Data: |
||
| Net assets, end of period (000's) |
$45,391 |
$35,197 |
| Net operating expenses to average daily net assets(b) * |
0.24 % |
0.22 % |
| Net investment income (loss) to average daily net assets* |
2.23 % |
2.91 % |
| Portfolio turnover rate(c) ** |
20 % |
8 % |
| Fees and expenses reimbursed and/or waived by GMO to average daily net assets:(d) * |
0.26 % |
0.28 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
Net expenses exclude expenses incurred indirectly through investment in the underlying funds, if any. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| (d) |
Ratio includes indirect fees waived or borne by GMO. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
32
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
International Quality ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Period from October 29, 2024 (commencement of operations) through June 30, 2025 | |
| Net asset value, beginning of period |
$28.05 |
$25.66 |
$25.00 |
| Income (loss) from investment operations: |
|||
| Net investment income (loss)† |
0.26 |
0.07 |
0.34 |
| Net realized & unrealized gain (loss) |
(0.53 ) |
2.46 |
0.36 |
| Total from investment operations |
(0.27 ) |
2.53 |
0.70 |
| Less distributions to shareholders: |
|||
| From net investment income |
(0.02 ) |
(0.14 ) |
(0.04 ) |
| Total distributions |
(0.02 ) |
(0.14 ) |
(0.04 ) |
| Net asset value, end of period |
$27.76 |
$28.05 |
$25.66 |
| Total return on net asset value(a) ** |
(0.91 )% |
9.89 % |
2.82 %(b) |
| Ratios/Supplemental Data: |
|||
| Net assets, end of period (000's) |
$297,076 |
$287,468 |
$56,446 |
| Net operating expenses to average daily net assets* |
0.60 % |
0.60 % |
0.60 % |
| Net investment income (loss) to average daily net assets* |
1.95 % |
0.42 % |
2.08 % |
| Portfolio turnover rate(c) ** |
13 % |
5 % |
9 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
The NAV return is based on the start of day values on October 29, 2024. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
33
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
International Value ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Period from October 29, 2024 (commencement of operations) through June 30, 2025 | |
| Net asset value, beginning of period |
$38.03 |
$29.12 |
$25.00 |
| Income (loss) from investment operations: |
|||
| Net investment income (loss)† |
0.76 |
0.36 |
1.00 |
| Net realized & unrealized gain (loss) |
2.63 |
9.47 |
3.25 |
| Total from investment operations |
3.39 |
9.83 |
4.25 |
| Less distributions to shareholders: |
|||
| From net investment income |
(0.15 ) |
(0.92 ) |
(0.13 ) |
| Total distributions |
(0.15 ) |
(0.92 ) |
(0.13 ) |
| Net asset value, end of period |
$41.27 |
$38.03 |
$29.12 |
| Total return on net asset value(a) ** |
8.96 % |
34.40 % |
17.09 %(b) |
| Ratios/Supplemental Data: |
|||
| Net assets, end of period (000's) |
$691,287 |
$448,765 |
$163,054 |
| Net operating expenses to average daily net assets* |
0.60 % |
0.60 % |
0.60 % |
| Net investment income (loss) to average daily net assets* |
3.97 % |
1.65 % |
5.66 % |
| Portfolio turnover rate(c) ** |
9 % |
4 % |
25 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
The NAV return is based on the start of day values on October 29, 2024. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
34
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout the period)
Power Infrastructure ETF
| Period from July 14, 2026 (commencement of operations) through August 31, 2026 (Unaudited) | |
| Net asset value, beginning of period |
$25.11 |
| Income (loss) from investment operations: |
|
| Net investment income (loss)† |
0.05 |
| Net realized & unrealized gain (loss) |
(0.36 ) |
| Total from investment operations |
(0.31 ) |
| Net asset value, end of period |
$24.80 |
| Total return on net asset value(a) ** |
(1.24 )% |
| Ratios/Supplemental Data: |
|
| Net assets, end of period (000's) |
$57,536 |
| Net operating expenses to average daily net assets* |
0.60 % |
| Net investment income (loss) to average daily net assets* |
1.75 % |
| Portfolio turnover rate(b) ** |
5 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
35
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
Systematic Investment Grade Credit ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Period from June 4, 2025 (commencement of operations) through June 30, 2025 | |
| Net asset value, beginning of period |
$25.97 |
$25.52 |
$25.00 |
| Income (loss) from investment operations: |
|||
| Net investment income (loss)† |
0.62 |
0.82 |
0.10 |
| Net realized & unrealized gain (loss) |
(1.01 ) |
0.43 |
0.42 |
| Total from investment operations |
(0.39 ) |
1.25 |
0.52 |
| Less distributions to shareholders: |
|||
| From net investment income |
(0.70 ) |
(0.73 ) |
— |
| From net realized gains |
— |
(0.07 ) |
— |
| Total distributions |
(0.70 ) |
(0.80 ) |
— |
| Net asset value, end of period |
$24.88 |
$25.97 |
$25.52 |
| Total return on net asset value(a) ** |
(1.52 )% |
4.97 % |
2.09 %(b) |
| Ratios/Supplemental Data: |
|||
| Net assets, end of period (000's) |
$23,631 |
$24,673 |
$6,381 |
| Net operating expenses to average daily net assets* |
0.25 % |
0.25 % |
0.25 % |
| Net investment income (loss) to average daily net assets* |
4.85 % |
4.81 % |
5.31 % |
| Portfolio turnover rate(c) ** |
65 % |
65 % |
— % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
The NAV return is based on the start of day values on June 4, 2025. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
36
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
U.S. Quality ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Year Ended June 30, 2025 |
Period from November 14, 2023 (commencement of operations) through June 30, 2024 | |
| Net asset value, beginning of period |
$38.75 |
$34.25 |
$31.01 |
$25.00 |
| Income (loss) from investment operations: |
||||
| Net investment income (loss)† |
0.13 |
0.19 |
0.30 |
0.19 |
| Net realized & unrealized gain (loss) |
4.29 |
4.54 |
3.14 |
5.96 |
| Total from investment operations |
4.42 |
4.73 |
3.44 |
6.15 |
| Less distributions to shareholders: |
||||
| From net investment income |
(0.14 ) |
(0.23 ) |
(0.20 ) |
(0.14 ) |
| Total distributions |
(0.14 ) |
(0.23 ) |
(0.20 ) |
(0.14 ) |
| Net asset value, end of period |
$43.03 |
$38.75 |
$34.25 |
$31.01 |
| Total return on net asset value(a) |
11.45 %** |
13.85 %** |
11.16 % |
24.62 %(b) ** |
| Ratios/Supplemental Data: |
||||
| Net assets, end of period (000's) |
$5,178,619 |
$3,463,674 |
$2,010,274 |
$830,803 |
| Net operating expenses to average daily net assets |
0.50 %* |
0.50 %* |
0.50 % |
0.50 %* |
| Net investment income (loss) to average daily net assets |
0.65 %* |
0.79 %* |
0.93 % |
1.01 %* |
| Portfolio turnover rate(c) |
11 %** |
4 %** |
15 % |
7 %** |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
The NAV return is based on the start of day values on November 14, 2023. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
37
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
U.S. Value ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from July 1, 2025 through February 28, 2026 |
Period from October 29, 2024 (commencement of operations) through June 30, 2025 | |
| Net asset value, beginning of period |
$29.25 |
$25.26 |
$25.00 |
| Income (loss) from investment operations: |
|||
| Net investment income (loss)† |
0.30 |
0.42 |
0.40 |
| Net realized & unrealized gain (loss) |
3.39 |
4.01 |
0.04 |
| Total from investment operations |
3.69 |
4.43 |
0.44 |
| Less distributions to shareholders: |
|||
| From net investment income |
(0.30 ) |
(0.44 ) |
(0.18 ) |
| Total distributions |
(0.30 ) |
(0.44 ) |
(0.18 ) |
| Net asset value, end of period |
$32.64 |
$29.25 |
$25.26 |
| Total return on net asset value(a) ** |
12.73 % |
17.72 % |
1.78 %(b) |
| Ratios/Supplemental Data: |
|||
| Net assets, end of period (000's) |
$107,053 |
$80,734 |
$52,547 |
| Net operating expenses to average daily net assets* |
0.50 % |
0.50 % |
0.50 % |
| Net investment income (loss) to average daily net assets* |
1.95 % |
2.34 % |
2.48 % |
| Portfolio turnover rate(c) ** |
19 % |
22 % |
53 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
The NAV return is based on the start of day values on October 29, 2024. |
| (c) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
38
GMO ETF Trust
Financial Highlights — (Continued)
(For a share outstanding throughout each period)
Ultra-Short Income ETF
| Six Months Ended August 31, 2026 (Unaudited) |
Period from October 27, 2025 (commencement of operations) through February 28, 2026 | |
| Net asset value, beginning of period |
$50.22 |
$50.00 |
| Income (loss) from investment operations: |
||
| Net investment income (loss)† |
1.11 |
0.78 |
| Net realized & unrealized gain (loss) |
(0.14 ) |
(0.03 ) |
| Total from investment operations |
0.97 |
0.75 |
| Less distributions to shareholders: |
||
| From net investment income |
(1.15 ) |
(0.53 ) |
| Total distributions |
(1.15 ) |
(0.53 ) |
| Net asset value, end of period |
$50.04 |
$50.22 |
| Total return on net asset value(a) ** |
1.97 % |
1.49 % |
| Ratios/Supplemental Data: |
||
| Net assets, end of period (000's) |
$32,529 |
$13,182 |
| Net operating expenses to average daily net assets* |
0.20 % |
0.20 % |
| Net investment income (loss) to average daily net assets* |
4.43 % |
4.64 % |
| Portfolio turnover rate(b) ** |
87 % |
43 % |
| (a) |
Total return on net asset value is based on the change in net asset value (“NAV”) of a share during the period and assumes reinvestment of dividends and distributions at NAV. The return shown does not reflect the deduction of taxes that a shareholder would pay on fund distributions or redemption of fund shares. |
| (b) |
Portfolio turnover rate excludes in-kind transactions, if any. |
| † |
Calculated using average shares outstanding throughout the period. |
| * |
Annualized. |
| ** |
Not annualized. |
See accompanying notes to the financial statements.
39
GMO ETF Trust
Notes to Financial Statements
August 31, 2026 (Unaudited)
1.
Organization
Each of GMO Domestic Resilience ETF, GMO Dynamic Allocation ETF, GMO International Quality ETF, GMO International Value ETF, GMO Power Infrastructure ETF (commenced operations on July 14, 2026), GMO Systematic Investment Grade Credit ETF, GMO U.S. Quality ETF, GMO U.S. Value ETF and GMO Ultra-Short Income ETF (each a “Fund” and collectively the “Funds”) is an exchange-traded fund (“ETF”) and a separate operating series of GMO ETF Trust (the “Trust”), a Delaware statutory trust since June 13, 2023 that is registered with the Securities and Exchange Commission as an open-end management investment company. The Funds are advised and managed by Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) an investment adviser registered under the Investment Advisers Act of 1940, as amended, and serves as the Funds’ investment adviser (the “Adviser”).
GMO Dynamic Allocation ETF may invest in other investment companies managed by GMO (including other series of GMO ETF Trust) and third parties (collectively, “underlying funds”).
Effective January 1, 2026 the fiscal year end of the Funds changed from June 30 to February 28/29. Accordingly, the Funds’ financial statements and related notes include information for the eight-month period ended February 28, 2026 of prior years, if applicable.
The following table provides information about the Funds' principal investment objectives and benchmark (if any):
| Fund Name |
Benchmark |
Investment Objective |
| Domestic Resilience ETF |
Not Applicable |
Total return |
| Dynamic Allocation ETF |
Not Applicable |
Positive total return |
| International Quality ETF |
Not Applicable |
Total return |
| International Value ETF |
Not Applicable |
Total return |
| Power Infrastructure ETF |
Not Applicable |
Total return |
| Systematic Investment Grade Credit ETF |
Bloomberg U.S. Corporate Index |
Total return in excess of its benchmark |
| U.S. Quality ETF |
Not Applicable |
Total return |
| U.S. Value ETF |
Not Applicable |
Total return |
| Ultra-Short Income ETF |
Not Applicable |
Current income consistent with preservation of capital |
2.
Significant Accounting Policies
Each Fund is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board Accounting Standards Codification Topic 946 “Financial Services – Investment Companies.”
The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates.
The Funds’ policies are in conformity with U.S. GAAP and have been consistently followed by the Funds in preparing the financial statements. The accompanying financial statements have been prepared in accordance with U.S. GAAP on the accrual basis of accounting.
Security Valuation
In accordance with the authoritative guidance on fair value measurements and disclosure under U.S. GAAP, the Funds disclose fair value of its investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure the fair value. The objective of a fair value measurement is to determine the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). Accordingly, the fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
Level 1: Valuations based on quoted prices for identical securities in active markets.
Level 2: Valuations determined using other significant direct or indirect observable inputs.
40
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
Level 3: Valuations based primarily on inputs that are unobservable and significant.
The valuation techniques used by the Funds to measure fair value during the period ended August 31, 2026 maximized the use of observable inputs and minimized the use of unobservable inputs.
Exchange-traded securities for which market quotations are readily available are valued at (i) the last sale price or (ii) official closing price or (iii) most recent quoted price published by the exchange (if no reported last sale or official closing price) or (iv) the quoted price provided by a pricing source (in the event GMO deems the private market to be a more reliable indicator of market value than the exchange). Shares of underlying funds and open-end registered investment companies are valued at their most recent net asset value.
Typically, the Funds value fixed income securities at the most recent price supplied by a pricing source determined by GMO (if a reliable updated price for a fixed income security is not available when a Fund calculates its NAV, the Fund will generally use the most recent reliable price to value that security).
The Funds’ Board of Trustees (the “Board”) has designated the Adviser as the valuation designee for the Funds under Rule 2a-5 of the Investment Company Act of 1940 (the “1940 Act”), subject to its oversight. The Adviser has adopted procedures and methodologies to fair value each Funds' investments whose market prices are not readily available or are deemed to be unreliable. Fair value determinations are made in good faith and in accordance with the fair value methodologies included in the Adviser-adopted valuation procedures. Due to the subjective and variable nature of fair value pricing, there can be no assurance that the Adviser will be able to obtain the fair value assigned to the investment upon the sale of such investment.
The following is a summary of the respective levels assigned to the Funds' securities and derivatives, if any, as of August 31, 2026:
| Description |
Level 1 |
Level 2 |
Level 3 |
Total |
| Domestic Resilience ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$36,224,651 |
$— |
$— |
$36,224,651 |
| Short-Term Investments |
155,859 |
— |
— |
155,859 |
| Total Investments |
36,380,510 |
— |
— |
36,380,510 |
| Total |
$36,380,510 |
$— |
$— |
$36,380,510 |
| Dynamic Allocation ETF |
||||
| Asset Valuation Inputs |
||||
| Investment Funds |
$45,114,449 |
$— |
$— |
$45,114,449 |
| Short-Term Investments |
284,097 |
— |
— |
284,097 |
| Total Investments |
45,398,546 |
— |
— |
45,398,546 |
| Total |
$45,398,546 |
$— |
$— |
$45,398,546 |
| International Quality ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$294,712,971 |
$— |
$— |
$294,712,971 |
| Short-Term Investments |
2,377,996 |
— |
— |
2,377,996 |
| Total Investments |
297,090,967 |
— |
— |
297,090,967 |
| Total |
$297,090,967 |
$— |
$— |
$297,090,967 |
| International Value ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$680,464,462 |
$— |
$— |
$680,464,462 |
| Preferred Stocks |
5,408,556 |
— |
— |
5,408,556 |
41
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
| Description |
Level 1 |
Level 2 |
Level 3 |
Total |
| International Value ETF (continued) |
||||
| Asset Valuation Inputs (continued) |
||||
| Short-Term Investments |
$3,820,438 |
$— |
$— |
$3,820,438 |
| Total Investments |
689,693,456 |
— |
— |
689,693,456 |
| Total |
$689,693,456 |
$— |
$— |
$689,693,456 |
| Power Infrastructure ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$56,699,983 |
$— |
$— |
$56,699,983 |
| Preferred Stocks |
507,244 |
— |
— |
507,244 |
| Short-Term Investments |
258,340 |
— |
— |
258,340 |
| Total Investments |
57,465,567 |
— |
— |
57,465,567 |
| Total |
$57,465,567 |
$— |
$— |
$57,465,567 |
| Systematic Investment Grade Credit ETF |
||||
| Asset Valuation Inputs |
||||
| Debt Obligations |
||||
| Corporate Debt |
$— |
$23,184,295 |
$— |
$23,184,295 |
| TOTAL DEBT OBLIGATIONS |
— |
23,184,295 |
— |
23,184,295 |
| Short-Term Investments |
571,782 |
— |
— |
571,782 |
| Total Investments |
571,782 |
23,184,295 |
— |
23,756,077 |
| Total |
$571,782 |
$23,184,295 |
$— |
$23,756,077 |
| U.S. Quality ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$5,155,746,980 |
$— |
$— |
$5,155,746,980 |
| Short-Term Investments |
21,955,042 |
— |
— |
21,955,042 |
| Total Investments |
5,177,702,022 |
— |
— |
5,177,702,022 |
| Total |
$5,177,702,022 |
$— |
$— |
$5,177,702,022 |
| U.S. Value ETF |
||||
| Asset Valuation Inputs |
||||
| Common Stocks |
$106,098,427 |
$— |
$— |
$106,098,427 |
| Short-Term Investments |
793,480 |
— |
— |
793,480 |
| Total Investments |
106,891,907 |
— |
— |
106,891,907 |
| Total |
$106,891,907 |
$— |
$— |
$106,891,907 |
| Ultra-Short Income ETF |
||||
| Asset Valuation Inputs |
||||
| Debt Obligations |
||||
| Asset-Backed Securities |
$— |
$22,887,101 |
$— |
$22,887,101 |
| U.S. Government |
8,171,816 |
361,809 |
— |
8,533,625 |
| TOTAL DEBT OBLIGATIONS |
8,171,816 |
23,248,910 |
— |
31,420,726 |
42
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
| Description |
Level 1 |
Level 2 |
Level 3 |
Total |
| Ultra-Short Income ETF (continued) |
||||
| Asset Valuation Inputs (continued) |
||||
| Short-Term Investments |
$74,711 |
$977,550 |
$— |
$1,052,261 |
| Total Investments |
8,246,527 |
24,226,460 |
— |
32,472,987 |
| Total |
$8,246,527 |
$24,226,460 |
$— |
$32,472,987 |
During the period from March 1, 2026 through August 31, 2026, there were no transfers into or out of Level 3 for the Funds.
Share Valuation
The net asset value (“NAV”) per share of each Fund is determined by dividing the value of the net assets of each of the Funds (i.e., the total value of a Fund's portfolio investments and other assets, less any liabilities) by the total number of shares outstanding of each Fund, rounded to the nearest cent. The NAV per share of each Fund is determined as of the close of regular trading on the New York Stock Exchange (“NYSE”), generally at 4:00 p.m. Eastern time. Any assets or liabilities denominated in currencies other than the U.S. dollar are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 p.m. Eastern time, at then current exchange rates or at such other rates as deemed appropriate.
Security Transactions and Investment Income
Security transactions are accounted for in the financial statements on trade date. Throughout the reporting period, investment transactions are generally accounted for no later than one business day following the trade date. Costs used in determining realized gains and losses on the sale of investment securities are based on specific identification. Dividend income is recorded on the ex-dividend date or, if later, when the Funds are informed of the ex-dividend date. Interest income is recognized on an accrual basis. Withholding taxes and reclaims on foreign dividends, if any, have been provided for in accordance with the Funds' understanding of the applicable country’s tax rules and rates.
Foreign Currency Translation
The market values of foreign securities, currency holdings and related assets and liabilities are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally at 4:00 pm Eastern time. Income and expenses denominated in foreign currencies are typically translated into U.S. dollars at the close of regular trading on the NYSE. Fluctuations in the value of currency holdings and other assets and liabilities resulting from changes in exchange rates are recorded as unrealized foreign currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on investment securities and income and expenses are translated on the respective dates of such transactions. The effects of changes in foreign currency exchange rates on investments in securities are not separated in the Statements of Operations from the effects of changes in market prices of those securities, but are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Funds may enter into repurchase agreements with banks and brokers. Under a repurchase agreement a Fund acquires a security for a relatively short period for cash and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The Fund, through its custodian, takes possession of securities it acquired under the repurchase agreement. The value of the securities acquired may be less than the amount owed to the Fund by the seller. If the seller in a repurchase agreement transaction defaults or enters into insolvency proceedings and the value of the securities subject to the repurchase agreement is insufficient, the Fund’s recovery of cash from the seller may be delayed and, even if the Fund is able to dispose of the securities, the Fund may incur a loss equal to the difference between the cash it paid and the value of the securities.
As of August 31, 2026, the Funds listed below had entered into repurchase agreements. The value of related collateral for each broker listed below exceeds the value of the repurchase agreements at period end. Repurchase agreements outstanding at the end of the period, if any, are listed in each applicable Fund’s Schedule of Investments.
43
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
| Fund Name |
Counterparty |
Value ($) |
Value (with associated collateral) ($) |
Weighted Average Maturity (days) |
| Ultra-Short Income ETF |
Daiwa Capital Markets America, Inc. |
977,550 |
994,109 |
N/A* |
| *The repurchase agreement has an open maturity date and can be closed by either party on demand. |
Dividends and Distributions
GMO Dynamic Allocation ETF, GMO International Quality ETF, GMO International Value ETF and GMO Power Infrastructure ETF pay out dividends from net investment income, if any, at least annually. GMO Domestic Resilience ETF, GMO U.S. Quality ETF and GMO U.S. Value ETF pay out dividends from net investment income, if any, quarterly. GMO Systematic Investment Grade Credit ETF and GMO Ultra-Short Income ETF pay out dividends from its net investment income, if any, monthly. Distributions of net realized capital gains, if any, generally are declared and paid at least annually, but a fund may make distributions on a more frequent basis for a fund to comply with the distribution requirements of the Internal Revenue Code of 1986, as amended (the “Code”) in all events in a manner consistent with the provisions of the Investment Company Act of 1940 (the “1940 Act”). Brokers may make available to their customers who own shares of each Fund the Depository Trust Company book-entry dividend reinvestment service. If this service is available and used, dividend distributions of both income and capital gains will automatically be reinvested in additional whole shares of each Fund purchased on the secondary market. Without this service, investors would receive their distributions in cash.
Income and capital gain distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP. Certain capital accounts in the financial statements are periodically adjusted for permanent differences in order to reflect their tax character. These adjustments have no impact on net assets or net asset value per share. Temporary differences that arise from recognizing certain items of income, expense, gain or loss in different periods for financial statement and tax purposes will likely reverse at some time in the future.
Federal Income and Foreign Tax Information
Each Fund has elected to be treated or intends to elect to be treated and intends to qualify each year as a separate regulated investment company under Subchapter M of the Code. Each Fund intends to distribute its net investment income, if any, and its net realized short-term and long-term capital gains, if any, after giving effect to any available capital loss carryforwards for U.S. federal income tax purposes. Therefore, each Fund makes no provision for U.S. federal income or excise taxes.
Taxes on foreign interest and dividend income are generally withheld in accordance with the applicable country’s tax treaty with the United States. The foreign withholding rates applicable to a Fund’s investments in certain jurisdictions may be higher if a significant portion of the Fund is held by non-U.S. shareholders.
As a result of court cases involving several countries across the European Union, certain Funds have filed tax reclaims in addition to treaty-based claims, in respect of previously withheld taxes on dividends earned (“EU tax reclaims”). These filings are subject to various administrative proceedings by each local jurisdiction’s tax authority, as well as judicial proceedings. EU tax reclaim and associated interest entitlements that have been recognized, if any, are reflected as Other income in the Statements of Operations. As a result of its entitlements to EU tax reclaims and related interest amounts, a Fund may incur contingent legal fees. Such fees are presented within Legal fees in the Statements of Operations. Related receivables, if any, are reflected as EU tax reclaims receivable in the Statements of Assets and Liabilities. Generally, unless GMO believes that recovery amounts are collectible and free from significant contingencies, recoveries will not be reflected in a Fund’s net asset value. In some cases, the amount of EU tax reclaims could be material to a Fund’s net asset value. If a shareholder redeems shares of a Fund before an EU tax reclaim (as finally determined) is reflected in the Fund’s net asset value, the shareholder will not realize the benefit of that reclaim. EU tax reclaims and related interest entitlements recognized by a Fund, if any, reduce the amount of foreign taxes, if any, that a Fund may elect to pass-through to its shareholders from a U.S. federal tax perspective. In certain circumstances and to the extent that EU tax reclaims recognized by a Fund were previously passed-through as foreign tax credits to its U.S. taxable shareholders, a Fund may enter into a closing agreement with the U.S. Internal Revenue Service. Doing so will enable a Fund to qualify and remit its tax liability, interest charges and related fees related to any recoveries (on behalf of its shareholders).
44
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
Each Fund may be subject to taxation on realized capital gains, repatriation proceeds and other transaction-based charges imposed by certain countries in which it invests. Transaction-based charges are generally calculated as a percentage of the transaction amount. Taxes related to capital gains realized during the period ended August 31, 2026, if any, are reflected as part of Net realized gain (loss) in the Statements of Operations. Changes in tax liabilities related to capital gain taxes on unrealized investment gains, if any, are reflected as part of Change in net unrealized appreciation (depreciation) in the Statements of Operations.
Foreign taxes paid by each Fund may be treated, to the extent permissible by the Code (and other applicable U.S. federal tax guidance) and if that Fund so elects, as if paid by U.S. shareholders of that Fund.
Distributions in excess of a Fund's tax basis earnings and profits, if significant, are reported in the Funds' financial statements as a return of capital.
As of February 28, 2026, certain Funds elected to defer to March 1, 2026 late-year ordinary losses and post-October capital losses. The Funds' loss deferrals are as follows:
| Fund Name |
Late-Year Ordinary Losses Deferral ($) |
Post-October Capital Losses Deferral ($) |
| Domestic Resilience ETF |
— |
— |
| Dynamic Allocation ETF |
— |
— |
| International Quality ETF |
— |
— |
| International Value ETF |
— |
— |
| Power Infrastructure ETF |
— |
— |
| Systematic Investment Grade Credit ETF |
— |
(5,555) |
| U.S. Quality ETF |
— |
— |
| U.S. Value ETF |
— |
— |
| Ultra-Short Income ETF |
— |
— |
As of February 28, 2026, certain Funds had capital loss carryforwards available to offset future realized gains, if any, to the extent permitted by the Code. Net capital losses are carried forward without expiration and generally retain their short-term and/or long-term tax character, as applicable. Utilization of the capital loss carryforwards, post-October capital losses, late-year ordinary losses, and losses realized subsequent to February 28, 2026, if any, could be subject to further limitations imposed by the Code related to share ownership activity. The Funds’ capital loss carryforwards are as follows:
| Fund Name |
Short-Term ($) |
Long-Term ($) |
| Domestic Resilience ETF |
(112) |
— |
| Dynamic Allocation ETF |
(13,389) |
— |
| International Quality ETF |
(147,636) |
(28,595) |
| International Value ETF |
(434,882) |
(205,585) |
| Power Infrastructure ETF |
— |
— |
| Systematic Investment Grade Credit ETF |
— |
— |
| U.S. Quality ETF |
(12,658,635) |
(3,237,657) |
| U.S. Value ETF |
(1,167,376) |
(73,604) |
| Ultra-Short Income ETF |
(2,259) |
— |
45
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
As of August 31, 2026, the approximate total cost, aggregate investment-level gross/net unrealized appreciation (depreciation) in the value of total investments, and the net unrealized appreciation (depreciation) of outstanding financial instruments, for U.S. federal income tax purposes were as follows:
| Fund Name |
Total Investments |
Outstanding Financial Instruments | |||
| Aggregate Cost ($) |
Gross Unrealized Appreciation ($) |
Gross Unrealized (Depreciation) ($) |
Net Unrealized Appreciation (Depreciation) ($) |
Net Unrealized Appreciation (Depreciation) ($) | |
| Domestic Resilience ETF |
34,029,323 |
3,846,618 |
(1,495,431) |
2,351,187 |
— |
| Dynamic Allocation ETF |
42,954,066 |
2,876,502 |
(432,022) |
2,444,480 |
— |
| International Quality ETF |
277,651,695 |
28,016,652 |
(8,577,380) |
19,439,272 |
— |
| International Value ETF |
622,430,659 |
72,257,450 |
(4,994,653) |
67,262,797 |
— |
| Power Infrastructure ETF |
57,321,444 |
2,678,342 |
(2,534,219) |
144,123 |
— |
| Systematic Investment Grade Credit ETF |
24,292,414 |
893 |
(537,230) |
(536,337) |
— |
| U.S. Quality ETF |
4,449,295,169 |
864,119,672 |
(135,712,819) |
728,406,853 |
— |
| U.S. Value ETF |
98,480,651 |
11,051,243 |
(2,639,987) |
8,411,256 |
— |
| Ultra-Short Income ETF |
32,517,894 |
2,521 |
(47,428) |
(44,907) |
— |
The Funds are subject to authoritative guidance related to the accounting and disclosure of uncertain tax positions under U.S. GAAP. A Fund may recognize an income tax liability related to an uncertain tax position under U.S. GAAP when the uncertain tax position has a less than 50% probability that it would be sustained upon examination by the tax authorities, based on technical merits. United States and non-U.S. tax rules (including the interpretation and application of tax laws) are subject to change. The Funds file tax returns and/or adopt certain tax positions in various jurisdictions. Non-U.S. taxes are provided for based on the Funds’ understanding of the prevailing tax rules of the non-U.S. markets in which they invest. Recently enacted tax rules, including interpretations of tax laws and tax legislation/initiatives currently under consideration in various jurisdictions, including the U.S., might affect the way the Funds and their investors are taxed prospectively and/or retroactively. Prior to the expiration of the relevant statutes of limitations, if any, the Funds are subject to examination by U.S. federal, state, local and non-U.S. jurisdictions with respect to the tax returns they have filed and the tax positions they have adopted. The Funds’ U.S. federal income tax returns are generally subject to examination by the Internal Revenue Service for a period of three years after they are filed. State, local and/or non-U.S. tax returns and/or other filings may be subject to examination for different periods, depending upon the tax rules of each applicable jurisdiction. As of August 31, 2026, each Fund has determined that no tax liability is required to be accrued in its financial statements related to uncertain tax positions for any tax years which are subject to examination.
Purchase and Sale of Fund Shares
Shares of each Fund are listed on NYSE Arca, Inc. (the “Exchange”), a national securities exchange and trade in the secondary market, where most investors may buy and sell them at market prices that change throughout the day. Such market prices may be lower, higher or equal to NAV. Accordingly, when transacting in the secondary market, investors may pay more than NAV when purchasing shares and receive less than NAV when selling shares. They may also be subject to brokerage commissions and charges. The Funds issue and redeem shares at NAV only in aggregations of a specified number of shares (“Creation Units”), generally in exchange for a basket of securities (“Basket”), together with a specified cash payment or, in certain circumstances, for an all cash payment. Unlike mutual funds, shares are not individually redeemable.
Indemnification
Under the Funds’ organizational documents, their officers and Trustees are indemnified against certain liabilities arising out of the performance of their duties to Funds. The Funds may enter into contracts that contain representations and that provide general indemnifications. The Funds’ maximum liability exposure under these arrangements is unknown, as future claims that have not yet occurred may be made against the Funds.
46
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
Segment Reporting
The Officers of the Funds act as the Funds' chief operating decision maker ("CODM") assessing performance and making decisions about resource allocation. The CODM has determined that each Fund operates as a single segment. The CODM monitors the operating results of each Fund as a whole and each Fund makes investments in accordance with its investment objective as outlined in its prospectus. The financial information used by the CODM is consistent with that presented in each Fund's Schedule of Investments, Statement of Changes in Net Assets and Financial Highlights.
The accounting policies of the segment are the same as those described in Note 2. Significant Accounting Policies. The financial statements include all the details of the segment assets, segment revenue and expenses, and reflect the financial results of the segment.
3.
Investment Advisory Agreement and Other Services
Under an investment advisory agreement between the Trust, on behalf of the Funds, and the Adviser (the “Advisory Agreement”), the Adviser provides investment advisory services to the Funds. For such investment advisory services, the Funds have agreed to pay the Adviser a unitary advisory fee payable at the annual rate equal to the percentage of each of the respective Funds' average daily net assets set forth in the table below:
| Domestic |
Dynamic |
International |
International |
Power |
Systematic |
U.S. |
U.S. |
Ultra-Short | |
| Advisory fee |
0.50% |
0.50%* |
0.60% |
0.60% |
0.60% |
0.25% |
0.50% |
0.50% |
0.20% |
| * |
GMO has contractually agreed to waive or reduce its management fee, through at least November 2, 2026, to the extent necessary to offset the management fees that are borne by the Fund as a result of the Fund's investment in underlying funds. |
In addition, the Adviser has contractually agreed to pay all expenses incurred by, and appropriately allocated to, the Funds except for the advisory fee; investment-related costs (such as interest charges on any borrowings, brokerage commissions and other expenses incurred in placing orders for the purchase and sale of securities and other investment instruments); taxes; proxy and shareholder meeting expenses (unless the need for a shareholder meeting is caused by the Adviser, such as a change of control of the Adviser); fees and expenses related to the provision of securities lending services; acquired fund fees and expenses (other than management and shareholder service fees paid to the Adviser attributable to the Funds’ investment in such acquired funds); legal fees or expenses in connection with any arbitration, litigation, or pending or threatened arbitration or litigation, including any settlements in connection therewith; legal fees incurred at the request or direction of a Fund service provider other than the Adviser; extraordinary (as mutually determined by the Board and the Adviser) or non-recurring expenses not incurred in the ordinary course of the Funds’ business; and distribution fees and expenses paid by the Funds under any distribution plan adopted pursuant to Rule 12b-1 under the 1940 Act.
GMO Dynamic Allocation ETF incurs fees and expenses indirectly as a shareholder in the underlying funds. For the period ended August 31, 2026 the Fund had annualized indirect fees and expenses of 0.26% of the Fund’s average daily net assets.
The Funds have adopted a Plan of Distribution (the “Distribution Plan”) that allows the Funds to pay distribution fees to Foreside Fund Services, LLC (the “Distributor”) and other firms that provide distribution services (“Service Providers”). Under the Distribution Plan, if a Service Provider provides distribution services, the Funds would pay distribution fees to the Distributor at an annual rate not to exceed 0.25% of a Fund's average daily net assets, pursuant to Rule 12b-1 under the 1940 Act. The Distributor would, in turn, pay the Service Provider out of its fees. The Board currently has determined not to implement any 12b-1 fees pursuant to the Plan. 12b-1 fees may only be imposed after approval by the Board.
State Street Bank & Trust Company (“State Street”) serves as administrator, custodian and transfer agent for the Funds. State Street maintains all necessary records of the Funds.
47
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
4.
Organizational Expenses and Offering Costs
The Adviser (and not the Funds) has agreed to pay all of the Funds’ organizational expenses and offering costs appropriately allocated to them. As a result, organizational expenses and offering costs of the Funds are not reflected in the Funds’ Statements of Assets and Liabilities or Statements of Operations. The Funds are not obligated to repay any such organizational expenses or offering costs paid by the Adviser.
5.
Purchases and Sales of Securities
Cost of purchases and proceeds from sales of securities, excluding in-kind transactions and short-term securities, for the period ended August 31, 2026 are noted in the table below:
| Fund Name |
Purchases ($) |
Purchases ($) |
Sales ($) |
Sales ($) |
| U.S. Government Securities |
Investment (Non-U.S. Government Securities) |
U.S. Government Securities |
Investment (Non-U.S. Government Securities) | |
| Domestic Resilience ETF |
— |
8,551,618 |
— |
302,999 |
| Dynamic Allocation ETF |
— |
11,041,226 |
— |
7,700,266 |
| International Quality ETF |
— |
36,961,639 |
— |
35,555,513 |
| International Value ETF |
— |
179,392,279 |
— |
43,366,754 |
| Power Infrastructure ETF |
— |
5,064,265 |
— |
2,115,403 |
| Systematic Investment Grade Credit ETF |
279,464 |
18,651,432 |
— |
16,528,814 |
| U.S. Quality ETF |
— |
636,426,931 |
— |
491,267,986 |
| U.S. Value ETF |
— |
45,812,697 |
— |
17,019,481 |
| Ultra-Short Income ETF |
6,246,984 |
34,445,605 |
1,062,145 |
20,948,633 |
In-kind transactions associated with creations and redemptions, for the period ended August 31, 2026 are noted in the table below:
| Fund Name |
Creations ($) |
Redemptions ($) |
| Domestic Resilience ETF |
2,307,137 |
13,884,550 |
| Dynamic Allocation ETF |
11,074,082 |
5,265,963 |
| International Quality ETF |
14,846,639 |
2,615,231 |
| International Value ETF |
201,274,616 |
133,820,700 |
| Power Infrastructure ETF |
54,077,372 |
— |
| Systematic Investment Grade Credit ETF |
1,261,872 |
3,584,377 |
| U.S. Quality ETF |
1,378,993,807 |
311,015,826 |
| U.S. Value ETF |
16,746,109 |
30,122,762 |
| Ultra-Short Income ETF |
— |
— |
48
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
6.
Principal Risks
The following chart identifies the principal risks associated with each Fund. Risks not marked for a particular Fund may, however, still apply to some extent to that Fund at various times.
| Domestic Resilience ETF |
Dynamic Allocation ETF |
International Quality ETF |
International Value ETF |
Power Infrastructure ETF |
Systematic Investment Grade Credit ETF |
U.S. Quality ETF |
U.S. Value ETF |
Ultra-Short Income ETF | |
| Management and Operational Risk |
● |
● |
● |
● |
● |
● |
● |
● |
● |
| Market Risk – Equities |
● |
● |
● |
● |
● |
● |
● |
||
| Market Disruption and Geopolitical Risk |
● |
● |
● |
● |
● |
● |
● |
● |
● |
| Focused Investment Risk |
● |
● |
● |
● |
● |
● |
● |
● |
|
| ETF Risks |
● |
● |
● |
● |
● |
● |
● |
● |
● |
| Smaller Company Risk |
● |
● |
● |
● |
● |
● |
● |
||
| Illiquidity Risk |
● |
● |
● |
● |
● |
● |
|||
| Non-U.S. Investment Risk |
● |
● |
● |
● |
● |
||||
| Market Risk - Fixed Income |
● |
● |
● | ||||||
| Currency Risk |
● |
● |
● |
● |
|||||
| Credit Risk |
● |
● |
● | ||||||
| Fund of Funds Risk |
● |
● |
● |
● |
|||||
| Counterparty Risk |
● |
● |
● | ||||||
| Derivatives and Short Sales Risk |
● |
● |
|||||||
| Value Investing Risk |
● |
● |
● |
||||||
| Futures Contracts Risk |
● |
● |
|||||||
| Commodities Risk |
● |
● |
|||||||
| Market Risk - Asset-Backed Securities |
● |
● | |||||||
| Large Transactions Risk |
● |
● |
|||||||
| Leveraging Risk |
● |
● |
|||||||
| Non-Diversified Funds |
● |
● |
● |
Investing in an ETF involves many risks. The risks of investing in the Funds depend on the types of investments in its portfolio and the investment strategies GMO employs on its behalf. This section does not describe every potential risk of investing in the Funds. The Funds could be subject to additional risks because of the types of investments they make and market conditions, which may change over time. The Statement of Additional Information includes more information about the Funds, their investments, and the related risks.
An investment in the Funds is not a bank deposit and, therefore, is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.
• Management and Operational Risk. A Fund runs the risk that GMO's investment techniques will fail to produce intended results. For some Funds, GMO uses quantitative models as part of its investment process. GMO's models may not accurately predict future market movements. In addition, GMO's models rely on assumptions and data that are subject to limitations (e.g., inaccuracies, staleness) that
49
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
could adversely affect their predictive value. A Fund also runs the risk that GMO's assessment of an investment, including a security's fundamental fair (or intrinsic) value, is wrong or that deficiencies in GMO's or another service provider's internal systems or controls will cause losses for the Fund or impair Fund operations.
• Market Risk – Equities. The market price of an equity in a Fund’s portfolio may decline due to factors affecting the issuer or its industry or the economy and equity markets generally. If a Fund purchases an equity for less than its fundamental fair (or intrinsic) value as assessed by GMO, a Fund runs the risk that the market price of the equity will not appreciate or will decline (for example, if GMO's assessment proves to be incorrect or the market fails to recognize the equity's intrinsic value). A Fund also may purchase equities that typically trade at higher multiples of current earnings than other securities, and the market prices of these equities often are more sensitive to changes in future earnings expectations and interest rates than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely to reduce the net asset value of a Fund's shares.
• Market Disruption and Geopolitical Risk. Geopolitical and other events (e.g., wars, pandemics, sanctions, terrorism, diplomatic tensions, dramatic changes in regulatory and/or foreign policy, cyberattacks, and rapid technological developments such as artificial intelligence) often disrupt securities markets and adversely affect the general economy or particular economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could exacerbate other risks or otherwise reduce the value of a Fund's investments.
• Focused Investment Risk. Investments in countries, regions, asset classes, sectors, industries, currencies, or issuers that are subject to the same or similar risk factors and investments whose market prices are closely correlated are subject to higher overall risk than investments that are more diversified or whose market prices are not as closely correlated.
• ETF Risks. Each Fund is an ETF and, as a result of this structure, is exposed to the following risks:
• Costs of Buying or Selling Shares Risk. Due to the costs of buying or selling Fund shares, including brokerage commissions imposed by brokers and the variance in bid-ask spreads, frequent trading of Fund shares may significantly reduce investment results and an investment in Fund shares may not be advisable for investors who anticipate regularly making small investments.
• Limited Authorized Participants, Market Makers and Liquidity Providers Risk. Because a Fund is an ETF, typically only a limited number of institutional investors (known as "Authorized Participants") are authorized to purchase and redeem shares directly from a Fund. Retail investors cannot transact directly with a Fund. In addition, there may be a limited number of market makers and/or liquidity providers in the marketplace to transact in Fund shares, there may be demand for Fund shares thereby increasing the market price above NAV, or lack of demand, which may decrease the market price below NAV, or in stressed market conditions, the market for Fund shares may become less liquid in response to deteriorating liquidity in the markets for a Fund's underlying portfolio holdings. As a result of these considerations, Fund shares may trade at a material premium or discount to net asset value ("NAV") or these factors may, in turn, lead to wider spreads between the bid and ask price of Fund shares. In addition, a Fund may face possible delisting if: (i) Authorized Participants exit the business or otherwise become unable to process creation and/or redemption orders and no other Authorized Participants step forward to perform these services, or (ii) market makers and/or liquidity providers exit the business or significantly reduce their business activities and no other entities step forward to perform their functions.
• Trading Risk. Shares of a Fund may trade on the NYSE Arca, Inc. (the "Exchange") above (premium) or below (discount) their NAV. In stressed market conditions, the market for Fund shares may become less liquid in response to deteriorating liquidity in the markets for a Fund's underlying portfolio holdings, which may increase the variance between the market price of the Fund shares and the value of its underlying holdings. This can be reflected as a spread between the bid and ask prices for the Fund shares quoted during the day or a premium or discount in the closing price from a Fund's NAV. In addition, although a Fund's shares are currently listed on the Exchange, there can be no assurance that an active trading market for Fund shares will develop or be maintained. Trading in Fund shares may be halted due to market conditions or for reasons that, in the view of the Exchange, make trading in shares of a Fund inadvisable.
• Cash Transactions Risk. A Fund may effect some of its creations and redemptions for cash, rather than in-kind securities. As a result, a Fund may have to sell portfolio securities at inopportune times in order to obtain the cash needed to meet redemption orders. This may cause a Fund to sell a security and recognize ordinary income, or a capital gain or loss that might not have been incurred if it had made a redemption in-kind. The use of cash creations and redemptions may also cause a Fund's shares to trade in the market at wider bid-ask spreads or greater premiums or discounts to a Fund's NAV. In effecting creations and redemptions in exchange for cash, a Fund may incur certain costs, including brokerage costs in connection with investing cash received and may
50
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
recognize capital gains in connection with cash redemptions, unlike an ETF that effects creations and redemptions only in-kind. In addition, costs could be imposed on a Fund which would have the effect of decreasing a Fund's NAV to the extent the costs are not offset by a transaction fee payable by an Authorized Participant.
• National Closed Market Trading Risk. To the extent that the underlying securities or other instruments held by a Fund trade on foreign exchanges or in foreign markets that may be closed when the securities exchange on which a Fund's shares trade is open, there are likely to be deviations between the current price of such an underlying security and the last quoted price for the underlying security (i.e., the Fund's quote from the closed foreign market). The impact of a closed foreign market on a Fund is likely to be greater where a large portion of a Fund's underlying securities or other instruments trade on that closed foreign market or when the foreign market is closed for unscheduled reasons. These deviations could result in premiums or discounts to a Fund's NAV that may be greater than those experienced by other ETFs.
• Smaller Company Risk. Smaller companies may have limited product lines, markets, or financial resources, lack the competitive strength of larger companies, have less experienced managers or depend on a few key employees. The securities of companies with smaller market capitalizations often are less widely held and trade less frequently and in lesser quantities, and their market prices often fluctuate more, than the securities of companies with larger market capitalizations.
• Illiquidity Risk. Low trading volume, lack of a market maker, large position size, or legal restrictions increase the risk that a Fund or an underlying fund is limited or prevented from selling particular securities or closing derivative positions at desirable prices at a particular time or at all.
• Non-U.S. Investment Risk. The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. securities markets are less stable, smaller, less liquid, and less regulated than U.S. securities markets, and the cost of trading in those markets often is higher than in U.S. securities markets. In addition, non-U.S. securities issuers often are not subject to as much regulation as U.S. issuers, and the reporting, recordkeeping, accounting, custody, and auditing standards to which those issuers are subject often are not as rigorous as U.S. standards. In addition, a Fund is subject to taxation by countries other than the United States, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends, interest, or other amounts it realizes or accrues in respect of non-U.S. investments; (ii) transactions in those investments; and (iii) repatriation of proceeds generated from the sale or other disposition of those investments. Also, a Fund needs a license to invest directly in securities traded in many non-U.S. securities markets, and a Fund is subject to the risk that its license is terminated or suspended. In some non-U.S. securities markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for securities prior to receipt) expose a Fund to credit and other risks. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of a Fund's investments. The risks above (such as substantial price fluctuations and market instability, illiquidity and lack of regulation) and other risks (e.g., nationalization, expropriation or other confiscation of assets of non-U.S. issuers, difficulties enforcing legal judgments or contractual rights and geopolitical risks) tend to be higher for investments in the securities of issuers tied economically to emerging countries. The economies of emerging countries often depend predominantly on only a few industries or commodities and often are more volatile than the economies of developed countries.
• Market Risk – Fixed Income. The market price of a fixed income investment can decline due to market-related factors, including rising interest or inflation rates and widening credit spreads, or decreased liquidity due, for example, to market uncertainty about the value of a fixed income investment (or class of fixed income investments).
• Currency Risk. Fluctuations in exchange rates can adversely affect the market value of a Fund's foreign currency holdings and investments denominated in foreign currencies.
• Credit Risk. A Fund runs the risk that the issuer or guarantor of a fixed income investment (including a sovereign or quasi-sovereign debt issuer) or the obligor of an obligation underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner or at all. The market price of a fixed income investment will normally decline as a result of the failure of an issuer, guarantor, or obligor to meet its payment obligations or in anticipation of such a failure. Below investment grade investments (commonly referred to as high yield or “junk” bonds) have speculative characteristics and are subject to greater credit risk than other fixed income investments. Negative changes in economic conditions or other circumstances are more likely to impair the ability of issuers of below investment grade investments to make principal and interest payments than issuers of investment grade investments. In addition, investments in emerging country sovereign or quasi-sovereign debt are subject to a heightened risk that the issuer responsible for repayment of the debt may be unable or unwilling to pay interest and repay principal when due, and the Fund may lack recourse against the issuer in the event of a default.
51
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
Investments in quasi-sovereign debt also are subject to the risk that the issuer will default independently of its sovereign. Investments in distressed or defaulted or other low quality debt investments generally are considered speculative and are subject to substantial risks not normally associated with investments in higher quality securities, including adverse business, financial or economic conditions that lead to their issuers’ payment defaults and insolvency proceedings. In particular, distressed or defaulted obligations might be repaid, if at all, only after lengthy workout or bankruptcy proceedings during which the issuer might not make any interest or other payments, and the Fund may incur additional expenses in its effort to be repaid. If GMO’s assessment of the eventual recovery value of a distressed or defaulted debt investment proves incorrect, the Fund may lose a substantial portion or all of its original investment or may be required to accept cash or instruments worth less than its original investment.
Securities issued by the U.S. Treasury historically have presented minimal credit risk. However, events in 2011 led to a downgrade in the long-term credit rating of U.S. bonds by several major rating agencies and introduced greater uncertainty about the repayment by the United States of its obligations. A further credit rating downgrade could decrease, and a U.S. credit default would decrease, the value of a Fund's investments and increase the volatility of a Fund's portfolio.
• Fund of Funds Risk. A Fund is indirectly exposed to all of the risks of an investment in the underlying funds in which it invests, including the risk that those underlying funds will not perform as expected. In addition, a Fund indirectly bears its pro rata portion of an underlying fund's fees and expenses in addition to the fees and expenses borne by the Fund. As a result, shareholders will be subject to two layers of fees and expenses when the Fund invests in underlying funds.
• Counterparty Risk. A Fund runs the risk that the counterparty to a derivatives contract or a clearing member used by a Fund to hold a cleared derivatives contract is unable or unwilling to make timely settlement payments, return a Fund’s collateral or otherwise honor its obligations.
• Derivatives and Short Sales Risk. The use of derivatives involves the risk that their value may not change as expected relative to changes in the value of the underlying assets, pools of assets, rates, currencies or indices. Derivatives also present other risks, including market risk, illiquidity risk, currency risk, credit risk, leveraging risk, commodities risk and counterparty risk. The market price of an option is affected by many factors, including changes in the market prices or dividend rates of underlying securities (or in the case of indices, the securities in such indices); the time remaining before expiration; changes in interest rates or exchange rates; and changes in the actual or perceived volatility of the relevant index or underlying securities. A Fund typically creates short investment exposure by selling securities short or by taking a derivative position in which the value of the derivative moves in the opposite direction from the price of an underlying asset, pool of assets, rate, currency or index. Specifically, the net asset value of a Fund’s shares will be adversely affected if the securities or other assets that are the subject of a Fund’s short exposures appreciate in value. The risk of loss associated with derivatives that provide short investment exposure and short sales of securities is theoretically unlimited.
• Value Investing Risk. Issuers whose securities GMO believes are undervalued may not realize their business potential, may never be recognized by the market as being undervalued and/or may be appropriately priced notwithstanding GMO's assessment. These and other factors may cause the price of value stocks to decline, resulting in losses to a Fund.
• Futures Contracts Risk. The loss to a Fund resulting from its use of futures contracts is potentially unlimited. Futures markets are highly volatile, and the use of futures contracts increases the volatility of a Fund’s net asset value. A liquid market may not exist for any particular futures contract at any particular time, and a Fund may be unable when it wishes to terminate its exposure under that contract. When a Fund uses futures contracts for hedging purposes, it runs the risk that changes in the prices of the contracts will not correlate perfectly with changes in the securities, index, or other asset underlying the contracts or movements in the prices of a Fund’s investments that are subject to the hedge. In addition, a Fund may be unable to recover or may be delayed in recovering margin or other amounts deposited with a futures commission merchant or futures clearinghouse. Foreign futures contracts are often less liquid and more volatile than U.S. futures contracts.
• Commodities Risk. Commodity prices can be extremely volatile, and exposure to commodities can cause the net asset value of a Fund's shares to decline or fluctuate significantly in a rapid and unpredictable manner.
• Market Risk - Asset-Backed Securities. The market price of asset-backed securities, like that of other fixed income investments, can decline for a variety of reasons, including increases in interest rates. In addition, the market price can decrease due to a reduction in or decrease in the reliability of their payment streams. Payment streams associated with asset-backed securities held by a Fund depend on many factors (e.g., the cash flow generated by the assets backing the securities, deal structure, and creditworthiness of any credit-support provider), and a problem in any of these factors can lead to a reduction in the payment stream GMO expected a Fund to
52
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
receive when the Fund purchased the asset-backed security. The liquidity of asset-backed securities (particularly below investment grade asset-backed securities) may change over time. During periods of deteriorating economic conditions, such as recessions, or periods of rising unemployment, delinquencies and losses generally increase, sometimes dramatically, for asset-backed securities whose underlying assets consist of loans, sales contracts, receivables and other obligations.
• Large Transactions Risk. To the extent that a large number of shares of a Fund is held by a single shareholder (e.g., an institutional investor or another GMO Fund) or a group of shareholders with a common investment strategy, a Fund is subject to the risk that a redemption by (or caused by) that shareholder or group will require a Fund to sell investments at disadvantageous prices, disrupt a Fund's operations, or force a Fund's liquidation.
• Leveraging Risk. The use of derivatives, short sales and securities lending can create leverage. Leverage increases a Fund’s losses when the value of its investments (including derivatives) declines. In addition, a Fund’s portfolio will be leveraged if it exercises its right to delay payment on a redemption and the value of a Fund’s assets declines between the time a redemption request is treated as being received by a Fund and the time a Fund liquidates assets to fund that redemption.
• Non-Diversified Funds. Each of GMO International Quality ETF and GMO Ultra-Short Income ETF is not a “diversified” investment company within the meaning of the 1940 Act. This means that the Fund is allowed to invest in the securities of a relatively small number of issuers. As a result, poor performance by a single investment is likely to have a greater impact on the Fund’s performance. In addition, Dynamic Allocation ETF may invest without limitation in GMO Funds that are not “diversified”.
7.
Capital Share Transactions
Each of the Funds shares are listed and traded on the Exchange each day that the Exchange is open for business (“Business Day”). Individual shares of the Funds may only be purchased and sold on the Exchange through a broker-dealer at market price. Because shares of the Funds trade at market prices rather than at NAV, shares of the Funds may trade at a price equal to NAV, greater than NAV (premium) or less than NAV (discount). The Funds issue their shares to and redeem their shares from, on a continuous basis, certain institutional investors known as “Authorized Participants” (typically market makers or other broker-dealers) only in large blocks of the Funds' shares known as Creation Units. Creation Unit transactions are generally conducted in exchange for the deposit or delivery of a portfolio of in-kind securities designated by the Funds and as needed, a specified amount of cash.
Most retail investors will not qualify as Authorized Participants, therefore, they will be unable to purchase or redeem the shares directly from the Funds. Rather, most retail investors will purchase shares of the Funds in the secondary market with the assistance of a broker, which will be subject to customary brokerage commissions or fees.
A purchase (i.e., creation) transaction fee may be imposed for the transfer and other transaction costs associated with the purchase of Creation Units. The Funds may adjust the creation transaction fee from time to time. In addition, a variable fee may be imposed for cash purchases, non-standard orders, or partial cash purchases of Creation Units. The variable fee is primarily designed to cover non-standard charges, e.g., brokerage, taxes, foreign exchange, execution, market impact, and other costs and expenses related to the execution of trades resulting from such transaction. The Funds may determine not to charge a variable fee on certain orders when the Adviser has determined that doing so is in the best interests of Fund shareholders. Investors who use the services of an Authorized Participant, broker or other such intermediary may be charged a fee for such services which may include an amount for the creation transaction fee and non-standard charges. Investors are responsible for the costs of transferring the securities constituting the deposit securities to the account of the Trust. The Adviser may retain all or a portion of the transaction fee to the extent the Adviser bears the expenses that otherwise would be borne by the Trust in connection with the issuance of a Creation Unit, which the transaction fee is designed to cover.
A redemption transaction fee may be imposed for the transfer and other transaction costs associated with the redemption of Creation Units. The Funds may adjust the redemption transaction fee from time to time. In addition, a variable fee, payable to the Funds, may be imposed for cash redemptions, non-standard orders, or partial cash redemptions for the Funds. The variable fee is primarily designed to cover non-standard charges, e.g., brokerage, taxes, foreign exchange, execution, market impact, and other costs and expenses related to the execution of trades resulting from such transaction. The Funds may determine not to charge a variable fee on certain orders when the Adviser has determined that doing so is in the best interests of the Funds' shareholders. Investors who use the services of an Authorized Participant, broker or other such intermediary may be charged a fee for such services which may include an amount for the redemption transaction fee and non-standard charges. Investors are responsible for the costs of transferring the securities constituting the Funds' securities to the account of the Trust.
53
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
The Declaration of Trust permits each Fund to issue an unlimited number of shares of beneficial interest (without par value). Transactions in the Funds’ shares were as follows:
| August 31, 2026 (Unaudited) |
February 28, 2026 | |||
| Shares |
Amount |
Shares |
Amount | |
| Domestic Resilience ETF(a) |
||||
| Shares sold |
360,000 |
$10,658,769 |
1,370,000 |
$35,153,181 |
| Shares repurchased |
(480,000 ) |
(14,403,169 ) |
(50,000 ) |
(1,286,460 ) |
| Net increase (decrease) |
(120,000 ) |
$(3,744,400 ) |
1,320,000 |
$33,866,721 |
| Dynamic Allocation ETF(b) |
||||
| Shares sold |
530,000 |
$14,450,923 |
1,290,000 |
$33,380,320 |
| Shares repurchased |
(200,000 ) |
(5,389,312 ) |
— |
— |
| Net increase (decrease) |
330,000 |
$9,061,611 |
1,290,000 |
$33,380,320 |
| International Quality ETF (c) |
||||
| Shares sold |
550,000 |
$14,970,155 |
8,250,000 |
$215,884,485 |
| Shares repurchased |
(100,000 ) |
(2,662,870 ) |
(200,000 ) |
(5,278,850 ) |
| Net increase (decrease) |
450,000 |
$12,307,285 |
8,050,000 |
$210,605,635 |
| International Value ETF (c) |
||||
| Shares sold |
8,500,000 |
$333,318,130 |
8,200,000 |
$281,564,840 |
| Shares repurchased |
(3,550,000 ) |
(135,145,515 ) |
(2,000,000 ) |
(66,215,610 ) |
| Net increase (decrease) |
4,950,000 |
$198,172,615 |
6,200,000 |
$215,349,230 |
| Power Infrastructure ETF(d) |
||||
| Shares sold |
2,320,000 |
$57,244,661 | ||
| Net increase (decrease) |
2,320,000 |
$57,244,661 | ||
| Systematic Investment Grade Credit ETF (c) |
||||
| Shares sold |
150,000 |
$3,795,425 |
850,000 |
$21,985,375 |
| Shares repurchased |
(150,000 ) |
(3,759,240 ) |
(150,000 ) |
(3,869,325 ) |
| Net increase (decrease) |
— |
$36,185 |
700,000 |
$18,116,050 |
| U.S. Quality ETF(c) |
||||
| Shares sold |
38,840,000 |
$1,542,922,090 |
42,070,000 |
$1,557,147,863 |
| Shares repurchased |
(7,890,000 ) |
(315,059,602 ) |
(11,370,000 ) |
(422,363,759 ) |
| Net increase (decrease) |
30,950,000 |
$1,227,862,488 |
30,700,000 |
$1,134,784,104 |
| U.S. Value ETF (c) |
||||
| Shares sold |
1,520,000 |
$45,836,028 |
1,600,000 |
$44,003,868 |
| Shares repurchased |
(1,000,000 ) |
(29,953,224 ) |
(920,000 ) |
(24,938,956 ) |
| Net increase (decrease) |
520,000 |
$15,882,804 |
680,000 |
$19,064,912 |
54
GMO ETF Trust
Notes to Financial Statements — (Continued)
August 31, 2026 (Unaudited)
| Six Months Ended August 31, 2026 (Unaudited) |
Period Ended February 28, 2026 | |||
| Shares |
Amount |
Shares |
Amount | |
| Ultra-Short Income ETF(e) |
||||
| Shares sold |
575,000 |
$28,812,881 |
262,500 |
$13,136,066 |
| Shares repurchased |
(187,500 ) |
(9,381,675 ) |
— |
— |
| Net increase (decrease) |
387,500 |
$19,431,206 |
262,500 |
$13,136,066 |
| (a) |
The period under the heading “Period Ended February 28, 2026” represents the period from September 30, 2025 (commencement of operations) through February 28, 2026. |
| (b) |
The period under the heading “Period Ended February 28, 2026” represents the period from October 13, 2025 (commencement of operations) through February 28, 2026. |
| (c) |
The period under the heading “Period Ended February 28, 2026” represents the period from July 1, 2025 through February 28, 2026. |
| (d) |
The period under the heading "Six Months Ended August 31, 2026" represents the period from July 14, 2026 (commencement of operations) through August 31, 2026. |
| (e) |
The period under the heading “Period Ended February 28, 2026” represents the period from October 27, 2025 (commencement of operations) through February 28, 2026. |
8.
Investments in affiliated companies and other Funds of the Trust
An affiliated company for the purposes of this disclosure is a company in which a Fund has or had direct ownership of at least 5% of the issuer’s voting securities or an investment in other funds of GMO ETF Trust or other funds managed by GMO. A summary of the Funds' transactions involving companies that are or were affiliates during the period ended August 31, 2026 is set forth below:
| Affiliate |
Value, beginning of period |
Purchases |
Sales Proceeds |
Dividend Income* |
Distributions of Realized Gains* |
Net Realized Gain (Loss) |
Net Increase/ Decrease in Unrealized Appreciation/ Depreciation |
Value, end of period |
| Dynamic Allocation ETF | ||||||||
| GMO Domestic Resilience ETF |
$1,054,786 |
$340,938 |
$62,702 |
$4,073 |
$— |
$9,419 |
$8,965 |
$1,351,406 |
| GMO International Quality ETF |
1,762,662 |
666,549 |
105,213 |
1,892 |
— |
2,604 |
5,641 |
2,332,243 |
| GMO International Value ETF |
3,609,240 |
1,141,860 |
556,004 |
16,359 |
— |
116,128 |
256,553 |
4,567,777 |
| GMO Power Infrastructure ETF |
— |
885,422 |
— |
— |
— |
— |
(7,969 ) |
877,453 |
| GMO U.S. Quality ETF |
3,357,426 |
1,322,064 |
459,664 |
13,112 |
— |
24,638 |
409,034 |
4,653,498 |
| GMO U.S. Value ETF |
3,478,418 |
1,119,452 |
448,552 |
37,653 |
— |
58,813 |
394,973 |
4,603,104 |
| Totals |
$13,262,532 |
$5,476,285 |
$1,632,135 |
$73,089 |
$— |
$211,602 |
$1,067,197 |
$18,385,481 |
| * |
The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2026 through August 31, 2026. The actual tax characterization of distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 28, 2027. |
9.
Subsequent events
Subsequent to August 31, 2026, GMO Ultra-Short Income ETF received redemption requests in the amount of $11,289,704.
55
GMO ETF Trust
Board Review of Investment Management Agreements
August 31, 2026 (Unaudited)
GMO International Quality ETF
Approval of renewal of investment advisory agreement for GMO International Quality ETF (the “Fund”). At a meeting on June 25, 2026, the Board of Trustees (the “Board” or the “Trustees”) of GMO ETF Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2026 of the investment advisory agreement between Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) and the Trust, on behalf of the Fund (collectively with other series of the Trust and GMO Trust, the “GMO funds”).
Throughout the year the Trustees considered information relevant to the renewal of the Fund’s investment advisory agreement at and apart from Board meetings. The Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) also requested information specifically for that purpose.
At a meeting on May 12, 2026, the Trustees discussed at length with representatives of GMO the investment performance of the Fund and the other GMO funds. Following that meeting, the Independent Trustees and their independent legal counsel met privately to discuss the extensive materials GMO had provided them at their request. At that meeting, the Independent Trustees asked their independent legal counsel to request additional information from GMO, which they received before and at the June 25, 2026 meeting of the Trustees. Prior to and at the June 25 meeting, the Independent Trustees considered that additional information. At the June 25 meeting, representatives of GMO answered additional questions from the Trustees, and at the end of the meeting the Independent Trustees met privately once again with their independent legal counsel.
Using various metrics, the Trustees considered the Fund’s investment performance, as well as the investment performance of the other GMO funds. The Trustees discussed how a fund with investment strategies similar to those used by GMO in managing the Fund would be expected to perform in various market conditions and considered whether the Fund’s performance had met those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of non-GMO funds and accounts in peer groups selected by third-party data services.
The Trustees considered the Fund’s expenses and its expense ratio (annual operating expenses per share as a percentage of average annual net asset value per share) as compared to the expense ratios of non-GMO funds in a peer group selected by a third-party data service.
The Trustees also considered the fees payable to GMO under the Fund’s investment advisory agreement. The Trustees reviewed information comparing the advisory fee payable by the Fund to the advisory fees of non-GMO funds in a peer group selected by a third-party data service.
The Trustees noted that the investment advisory fee is structured as a “unitary fee,” meaning that the Fund pays no expenses other than the advisory fee and certain expenses customarily excluded from unitary fee arrangements, and that GMO is responsible for compensating the Fund’s other service providers and paying the Fund’s other expenses out of its own fee and resources.
The Trustees also considered the non-investment management services GMO provides to the Fund, including but not limited to valuation, legal and compliance, board support, accounting, operational, operational risk management, and technology services.
The Trustees also considered information provided to them by GMO regarding its profits from managing the Fund and the GMO funds overall. The Trustees reviewed GMO’s methodology in preparing that information and noted that it was materially consistent with the methodology used in the prior year. They also noted that other methods of calculating profitability could produce materially different results. The Trustees took note of “fallout benefits” realized by GMO from its management of the Fund and the other GMO funds.
The Trustees considered whether the fees payable by the Fund to GMO reflected possible economies of scale to GMO at the Fund’s recent asset levels. The Trustees noted that the Fund’s advisory fee did not have any breakpoints and GMO’s reasons for not including breakpoints.
The Trustees also considered, as they had during the course of the year, the experience and sophistication of GMO and its personnel (including, among others, management and investment-management personnel and legal, tax, accounting, compliance, and risk-management personnel). In addition, the Trustees considered the resources GMO employed in managing the Fund, GMO’s organization, its reputation and relationship with Fund shareholders, its risk-management policies, its proxy voting policies, and other aspects of GMO’s business relevant to the nature and quality of its services to the Fund.
56
GMO ETF Trust
Board Review of Investment Management Agreements — (Continued)
August 31, 2026 (Unaudited)
After reviewing these and other factors, the Trustees concluded that the nature, extent, and quality of GMO’s services to the Fund supported their approval of the Fund’s investment advisory agreement and that the fee charged under that agreement was reasonable. In the Trustees’ deliberations, each Trustee weighed specific factors as that Trustee thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s investment advisory agreement for another year.
GMO International Value ETF
Approval of renewal of investment advisory agreement for GMO International Value ETF (the “Fund”). At a meeting on June 25, 2026, the Board of Trustees (the “Board” or the “Trustees”) of GMO ETF Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2026 of the investment advisory agreement between Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) and the Trust, on behalf of the Fund (collectively with other series of the Trust and GMO Trust, the “GMO funds”).
Throughout the year the Trustees considered information relevant to the renewal of the Fund’s investment advisory agreement at and apart from Board meetings. The Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) also requested information specifically for that purpose.
At a meeting on May 12, 2026, the Trustees discussed at length with representatives of GMO the investment performance of the Fund and the other GMO funds. Following that meeting, the Independent Trustees and their independent legal counsel met privately to discuss the extensive materials GMO had provided them at their request. At that meeting, the Independent Trustees asked their independent legal counsel to request additional information from GMO, which they received before and at the June 25, 2026 meeting of the Trustees. Prior to and at the June 25 meeting, the Independent Trustees considered that additional information. At the June 25 meeting, representatives of GMO answered additional questions from the Trustees, and at the end of the meeting the Independent Trustees met privately once again with their independent legal counsel.
Using various metrics, the Trustees considered the Fund’s investment performance, as well as the investment performance of the other GMO funds. The Trustees discussed how a fund with investment strategies similar to those used by GMO in managing the Fund would be expected to perform in various market conditions and considered whether the Fund’s performance had met those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of a composite of accounts with similar objectives managed by GMO and the performance of non-GMO funds and accounts in peer groups selected by third-party data services.
The Trustees considered the Fund’s expenses and its expense ratio (annual operating expenses per share as a percentage of average annual net asset value per share) as compared to the expense ratios of non-GMO funds in a peer group selected by a third-party data service.
The Trustees also considered the fees payable to GMO under the Fund’s investment advisory agreement. The Trustees reviewed information comparing the advisory fee payable by the Fund to the advisory fees of non-GMO funds in a peer group selected by a third-party data service and to fees GMO received for providing management and other services to a mutual fund with an investment strategy similar to that of the Fund. The Trustees noted the differences in the services provided by GMO to the Fund and to that mutual fund, as well as the enterprise, regulatory, and other risks borne by GMO in managing the Fund as compared to the risks borne by GMO in providing management and other services to that mutual fund.
The Trustees noted that the investment advisory fee is structured as a “unitary fee,” meaning that the Fund pays no expenses other than the advisory fee and certain expenses customarily excluded from unitary fee arrangements, and that GMO is responsible for compensating the Fund’s other service providers and paying the Fund’s other expenses out of its own fee and resources.
The Trustees also considered the non-investment management services GMO provides to the Fund, including but not limited to valuation, legal and compliance, board support, accounting, operational, operational risk management, and technology services.
The Trustees also considered information provided to them by GMO regarding its profits from managing the Fund and the GMO funds overall. The Trustees reviewed GMO’s methodology in preparing that information and noted that it was materially consistent with the methodology used in the prior year. They also noted that other methods of calculating profitability could produce materially different results. The Trustees took note of “fallout benefits” realized by GMO from its management of the Fund and the other GMO funds.
57
GMO ETF Trust
Board Review of Investment Management Agreements — (Continued)
August 31, 2026 (Unaudited)
The Trustees considered whether the fees payable by the Fund to GMO reflected possible economies of scale to GMO at the Fund’s recent asset levels. The Trustees noted that the Fund’s advisory fee did not have any breakpoints and GMO’s reasons for not including breakpoints.
The Trustees also considered, as they had during the course of the year, the experience and sophistication of GMO and its personnel (including, among others, management and investment-management personnel and legal, tax, accounting, compliance, and risk-management personnel). In addition, the Trustees considered the resources GMO employed in managing the Fund, GMO’s organization, its reputation and relationship with Fund shareholders, its risk-management policies, its proxy voting policies, and other aspects of GMO’s business relevant to the nature and quality of its services to the Fund.
After reviewing these and other factors, the Trustees concluded that the nature, extent, and quality of GMO’s services to the Fund supported their approval of the Fund’s investment advisory agreement and that the fee charged under that agreement was reasonable. In the Trustees’ deliberations, each Trustee weighed specific factors as that Trustee thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s investment advisory agreement for another year.
GMO Power Infrastructure ETF
Approval of initial management agreement for GMO Power Infrastructure ETF (the “Fund”). At a meeting on June 25, 2026, the Board of Trustees (the “Trustees”) of GMO ETF Trust (the “Trust”) approved for an initial two-year term commencing upon its execution, the investment advisory agreement between Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) and the Trust, on behalf of the Fund. In approving the initial investment advisory agreement, the Trustees considered information they believed, in light of the legal advice furnished to them, to be relevant, including information relating specifically to the Fund as well as to the Trust generally and the other series of the Trust and GMO Trust (collectively, the “GMO funds”).
At a meeting on June 25, 2026, the Trustees discussed materials provided by GMO for purposes of considering GMO’s proposal to establish the Fund as a new series of the Trust and a proposed investment advisory agreement between the Trust, on behalf of the Fund, and GMO. During this meeting, the Trustees met with representatives from GMO’s Focused Equity Team, GMO’s Product Development Team, and GMO’s Legal Group and asked questions relating to the Fund and the materials GMO provided the Trustees in advance of the meeting.
Since the Fund had not yet commenced operations, the Trustees were unable to consider its investment performance. The Trustees therefore considered the performance of the other GMO funds, including funds whose investments were managed by GMO’s Focused Equity Team, the investment division of GMO that would be managing the Fund’s investments.
The Trustees considered the fees to be paid to GMO under the Fund’s investment advisory agreement and the Fund’s estimated expense ratio (annual operating expenses per share as a percentage of average annual net asset value per share) as compared to the advisory fees and expense ratios of other GMO funds managed by GMO’s Focused Equity Team using a substantially similar investment process. The Trustees noted that the investment advisory fee is structured as a “unitary fee,” meaning that the ETF will pay no expenses other than the advisory fee and certain expenses customarily excluded from unitary fee arrangements, and that GMO will be responsible for compensating the Fund’s other service providers and paying the Fund’s other expenses out of its own fee and resources. The Trustees also considered the Fund’s estimated expense ratio as compared to the expense ratios of funds managed by other managers determined by GMO to have similar investment characteristics.
The Trustees also considered that the non-investment management services to be provided by GMO to the Fund, including but not limited to valuation, legal and compliance, board support, accounting, operational, operational risk management, and technology services, were the same as the services provided by GMO under its current management agreements with other GMO funds.
Since the Fund had not yet commenced operations, no information regarding GMO’s profitability with respect to the Fund was available to the Trustees. The Trustees did, however, consider information provided to them by GMO regarding its overall profits from managing the other GMO funds. The Trustees also considered how the proposed fees compared to fees paid by other GMO funds and took note of “fallout benefits” that would be realized by GMO from its management of the Fund and the other GMO funds. As the Fund had not yet commenced operations, the Trustees did not consider possible economies of scale to GMO associated with managing the Fund.
58
GMO ETF Trust
Board Review of Investment Management Agreements — (Continued)
August 31, 2026 (Unaudited)
The Trustees also considered, as they had during the course of the year, the experience and sophistication of GMO and its personnel (including, among others, management and investment-management personnel, and legal, tax, accounting, compliance, and risk-management personnel). In addition, the Trustees considered the resources GMO would employ in managing the Fund, GMO’s organization, its reputation, its risk-management policies, its proxy voting policies, and other aspects of GMO’s business relevant to the nature and quality of its services to be provided to the Fund.
After reviewing these and other factors, the Trustees concluded, in the context of their overall review of the Fund’s initial investment advisory agreement, that the nature, extent, and quality of GMO’s services to be provided to the Fund supported their approval of the Fund’s investment advisory agreement and that the fee to be charged under that agreement was reasonable.
In the Trustees’ deliberations, each Trustee weighted specific factors as that Trustee thought appropriate. Following their deliberations, the Trustees who are not “interested persons” of the Trust voting separately, and then all Trustees voting together, approved the Fund’s initial investment advisory agreement.
GMO Systematic Investment Grade Credit ETF
Approval of renewal of investment advisory agreement for GMO Systematic Investment Grade Credit ETF (the “Fund”). At a meeting on June 25, 2026, the Board of Trustees (the “Board” or the “Trustees”) of GMO ETF Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2026 of the investment advisory agreement between Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) and the Trust, on behalf of the Fund (collectively with other series of the Trust and GMO Trust, the “GMO funds”).
Throughout the year the Trustees considered information relevant to the renewal of the Fund’s investment advisory agreement at and apart from Board meetings. The Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) also requested information specifically for that purpose.
At a meeting on May 12, 2026, the Trustees discussed at length with representatives of GMO the investment performance of the Fund and the other GMO funds. Following that meeting, the Independent Trustees and their independent legal counsel met privately to discuss the extensive materials GMO had provided them at their request. At that meeting, the Independent Trustees asked their independent legal counsel to request additional information from GMO, which they received before and at the June 25, 2026 meeting of the Trustees. Prior to and at the June 25 meeting, the Independent Trustees considered that additional information. At the June 25 meeting, representatives of GMO answered additional questions from the Trustees, and at the end of the meeting the Independent Trustees met privately once again with their independent legal counsel.
Using various metrics, the Trustees considered the Fund’s investment performance, as well as the investment performance of the other GMO funds. The Trustees discussed how a fund with investment strategies similar to those used by GMO in managing the Fund would be expected to perform in various market conditions and considered whether the Fund’s performance had met those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of non-GMO funds and accounts in peer groups selected by third-party data services.
The Trustees considered the Fund’s expenses and its expense ratio (annual operating expenses per share as a percentage of average annual net asset value per share) as compared to the expense ratios of non-GMO funds in a peer group selected by a third-party data service.
The Trustees also considered the fees payable to GMO under the Fund’s investment advisory agreement. The Trustees reviewed information comparing the advisory fee payable by the Fund to the advisory fees of non-GMO funds in a peer group selected by a third-party data service.
The Trustees noted that the investment advisory fee is structured as a “unitary fee,” meaning that the Fund pays no expenses other than the advisory fee and certain expenses customarily excluded from unitary fee arrangements, and that GMO is responsible for compensating the Fund’s other service providers and paying the Fund’s other expenses out of its own fee and resources.
The Trustees also considered the non-investment management services GMO provides to the Fund, including but not limited to valuation, legal and compliance, board support, accounting, operational, operational risk management, and technology services.
59
GMO ETF Trust
Board Review of Investment Management Agreements — (Continued)
August 31, 2026 (Unaudited)
The Trustees also considered information provided to them by GMO regarding its profits from managing the Fund and the GMO funds overall. The Trustees reviewed GMO’s methodology in preparing that information and noted that it was materially consistent with the methodology used in the prior year. They also noted that other methods of calculating profitability could produce materially different results. The Trustees took note of “fallout benefits” realized by GMO from its management of the Fund and the other GMO funds.
The Trustees considered whether the fees payable by the Fund to GMO reflected possible economies of scale to GMO at the Fund’s recent asset levels. The Trustees noted that the Fund’s advisory fee did not have any breakpoints and GMO’s reasons for not including breakpoints.
The Trustees also considered, as they had during the course of the year, the experience and sophistication of GMO and its personnel (including, among others, management and investment-management personnel and legal, tax, accounting, compliance, and risk-management personnel). In addition, the Trustees considered the resources GMO employed in managing the Fund, GMO’s organization, its reputation and relationship with Fund shareholders, its risk-management policies, its proxy voting policies, and other aspects of GMO’s business relevant to the nature and quality of its services to the Fund.
After reviewing these and other factors, the Trustees concluded that the nature, extent, and quality of GMO’s services to the Fund supported their approval of the Fund’s investment advisory agreement and that the fee charged under that agreement was reasonable.
In the Trustees’ deliberations, each Trustee weighed specific factors as that Trustee thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s investment advisory agreement for another year.
GMO U.S. Quality ETF
Approval of renewal of investment advisory agreement for GMO U.S. Quality ETF (the “Fund”). At a meeting on June 25, 2026, the Board of Trustees (the “Board” or the “Trustees”) of GMO ETF Trust (the “Trust”) approved the renewal for an additional twelve-month period beginning on June 30, 2026 of the investment advisory agreement between Grantham, Mayo, Van Otterloo & Co. LLC (“GMO”) and the Trust, on behalf of the Fund (collectively with other series of the Trust and GMO Trust, the “GMO funds”).
Throughout the year the Trustees considered information relevant to the renewal of the Fund’s investment advisory agreement at and apart from Board meetings. The Trustees who are not “interested persons” of the Trust (the “Independent Trustees”) also requested information specifically for that purpose.
At a meeting on May 12, 2026, the Trustees discussed at length with representatives of GMO the investment performance of the Fund and the other GMO funds. Following that meeting, the Independent Trustees and their independent legal counsel met privately to discuss the extensive materials GMO had provided them at their request. At that meeting, the Independent Trustees asked their independent legal counsel to request additional information from GMO, which they received before and at the June 25, 2026 meeting of the Trustees. Prior to and at the June 25 meeting, the Independent Trustees considered that additional information. At the June 25 meeting, representatives of GMO answered additional questions from the Trustees, and at the end of the meeting the Independent Trustees met privately once again with their independent legal counsel.
Using various metrics, the Trustees considered the Fund’s investment performance, as well as the investment performance of the other GMO funds. The Trustees discussed how a fund with investment strategies similar to those used by GMO in managing the Fund would be expected to perform in various market conditions and considered whether the Fund’s performance had met those expectations. In addition, the Trustees considered the Fund’s performance in light of various risk and performance measures and as compared to the performance of a composite of accounts with similar objectives managed by GMO and the performance of non-GMO funds and accounts in peer groups selected by third-party data services.
The Trustees considered the Fund’s expenses and its expense ratio (annual operating expenses per share as a percentage of average annual net asset value per share) as compared to the expense ratios of non-GMO funds in a peer group selected by a third-party data service.
The Trustees also considered the fees payable to GMO under the Fund’s investment advisory agreement. The Trustees reviewed information comparing the advisory fee payable by the Fund to the advisory fees of non-GMO funds in a peer group selected by a third-party data service, to fees GMO received for providing management and other services to a mutual fund with an investment
60
GMO ETF Trust
Board Review of Investment Management Agreements — (Continued)
August 31, 2026 (Unaudited)
strategy similar to that of the Fund, and to the fees shown on GMO’s fee schedule for other pooled investment vehicles and separately managed accounts that it managed or sub-advised with an investment strategy similar to that of the Fund. The Trustees noted the differences in the services provided by GMO to the Fund, to that mutual fund, to those other vehicles, and to those other accounts, as well as the enterprise, regulatory, and other risks borne by GMO in managing the Fund as compared to the risks borne by GMO in providing management and other services to that mutual fund and managing or sub-advising those other vehicles and those other accounts.
The Trustees noted that the investment advisory fee is structured as a “unitary fee,” meaning that the Fund pays no expenses other than the advisory fee and certain expenses customarily excluded from unitary fee arrangements, and that GMO is responsible for compensating the Fund’s other service providers and paying the Fund’s other expenses out of its own fee and resources.
The Trustees also considered the non-investment management services GMO provides to the Fund, including but not limited to valuation, legal and compliance, board support, accounting, operational, operational risk management, and technology services.
The Trustees also considered information provided to them by GMO regarding its profits from managing the Fund and the GMO funds overall. The Trustees reviewed GMO’s methodology in preparing that information and noted that it was materially consistent with the methodology used in the prior year. They also noted that other methods of calculating profitability could produce materially different results. The Trustees took note of “fallout benefits” realized by GMO from its management of the Fund and the other GMO funds.
The Trustees considered whether the fees payable by the Fund to GMO reflected possible economies of scale to GMO at the Fund’s recent asset levels. The Trustees noted that the Fund’s advisory fee did not have any breakpoints and GMO’s reasons for not including breakpoints.
The Trustees also considered, as they had during the course of the year, the experience and sophistication of GMO and its personnel (including, among others, management and investment-management personnel and legal, tax, accounting, compliance, and risk-management personnel). In addition, the Trustees considered the resources GMO employed in managing the Fund, GMO’s organization, its reputation and relationship with Fund shareholders, its risk-management policies, its proxy voting policies, and other aspects of GMO’s business relevant to the nature and quality of its services to the Fund. The Trustees also reviewed information regarding average brokerage commissions paid by the Fund and by a separately managed account with similar investment strategies and objectives advised by GMO.
After reviewing these and other factors, the Trustees concluded that the nature, extent, and quality of GMO’s services to the Fund supported their approval of the Fund’s investment advisory agreement and that the fee charged under that agreement was reasonable.
In the Trustees’ deliberations, each Trustee weighed specific factors as that Trustee thought appropriate. Following their deliberations, the Independent Trustees voting separately, and then all Trustees voting together, approved the renewal of the Fund’s investment advisory agreement for another year.
61
Investment Adviser
Grantham, Mayo, Van Otterloo & Co. LLC
53 State Street
Boston, MA 02109
Administrator, Transfer Agent and Custodian
State Street Bank & Trust Company
One Congress Street, Suite 1
Boston, MA 02114
Distributor
Foreside Fund Services, LLC
Three Canal Plaza, Suite 100
Portland, ME 04101
Independent Registered Public Accounting Firm
PricewaterhouseCoopers, LLP
101 Seaport Boulevard, Suite 500
Boston MA 02210
Legal Counsel
Ropes & Gray LLP
Prudential Tower
800 Boylston Street
Boston, MA 02199
Item 8. Changes in and Disagreements with Accountants for Open-End Management Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-End Management Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-End Management Investment Companies.
Not applicable.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
Filed under Item 7(a) of this Form.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable to this registrant.
Item 13. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable to this registrant.
Item 14. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable to this registrant.
Item 15. Submission of Matters to a Vote of Security Holders.
There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s Board of Trustees.
Item 16. Controls and Procedures.
| (a) | The registrant’s Principal Executive Officer and Principal Financial Officer have concluded as of a date within 90 days of the filing of this report, based on their evaluation of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended) that the design and operation of such procedures are effective to provide reasonable assurance that information required to be disclosed by the registrant on Form N-CSR is recorded, processed, summarized, and reported within the time periods specified in the Commission’s rules and forms. |
| (b) | There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940, as amended) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
Item 17. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies
Not applicable to this registrant.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
| (a)(1) | Not applicable for semi-annual reports. | |
| (a)(2) | Not applicable. | |
| (a)(3) | Certifications for the Principal Executive Officer and the Principal Financial Officer of the registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940, as amended (17 CFR 270.30a-2(a)), are attached hereto. | |
| (a)(4) | Not applicable. | |
| (a)(5) | Not applicable. | |
| (b) | Certifications by the Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, as amended, are attached hereto. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
GMO ETF Trust
| By: | /s/ Tara Pari | |
| Tara Pari | ||
| Principal Executive Officer | ||
| Date: | November 5, 2026 | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By: | /s/ Tara Pari | |
| Tara Pari | ||
| Principal Executive Officer | ||
| Date: | November 5, 2026 | |
| By: | /s/ Betty Maganzini | |
| Betty Maganzini | ||
| Principal Financial Officer | ||
| Date: | November 5, 2026 | |
来源:SEC EDGAR · 本站存档